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vABSTRACT
A guide RNA (gRNA) directs the function of a CRISPR protein effector to a target
gene of choice, providing a versatile programmable platform for engineering diverse
modes of synthetic regulation (edit, silence, induce, bind). However, the fact that
gRNAs are constitutively active places limitations on the ability to confine gRNA
activity to a desired location and time. To achieve programmable control over the
scope of gRNA activity, here we apply principles from dynamic RNA nanotechnol-
ogy to engineer conditional guide RNAs (cgRNAs) whose activity is dependent on
the presence or absence of an RNA trigger. These cgRNAs are programmable at two
levels, with the trigger-binding sequence controlling the scope of the effector activ-
ity and the target-binding sequence determining the subject of the effector activity.
There are two possible logical directions for single-input cgRNAs: constitutively
active cgRNAs that are conditionally inactivated by an RNA trigger (ON→OFF
logic) and constitutively inactive cgRNAs that are conditionally activated by an
RNA trigger (OFF→ON logic). Using an in vitro assay for cgRNA activity with
synthetic trigger, in vitro transcribed cgRNA, and recombinant dCas9, we observe
a conditional (ON→OFF logic) response for a set of four allosteric constitutively
active cgRNAs with a median ≈6% crosstalk between noncognate cgRNA/trigger
pairs. Motivated by the observed lack of conditional response of this mechanism
when ported to E. coli, we describe a systematic study of unstructured sequence
inserts into the standard gRNA structure and report the conditional response of a set
of 34 candidate cgRNAs in living cells. Molecular mechanisms for both ON→OFF
and OFF→ON cgRNAs are demonstrated in E. coli. For each mechanism, auto-
mated sequence design is performed using the reaction pathway designer within
NUPACK to produce an orthogonal library of cgRNAs that respond to different
RNA triggers. In E. coli expressing cgRNAs, triggers, and silencing dCas9 as the
protein effector, we observe a median conditional response of ≈15-fold for a library
of three orthogonal ON→OFF “splinted switch” cgRNA/trigger pairs, and ≈3-fold
for a library of three orthogonal OFF→ON “toehold switch” cgRNA/trigger pairs;
the median crosstalk within each library is <2% and ≈20% for the two mecha-
nisms, respectively. By providing programmable control over both the scope and
target of protein effector function, cgRNA regulators offer a promising platform for
conditional gene regulation and synthetic biology.
vi
PUBLISHED CONTENT AND CONTRIBUTIONS
1. Hanewich-Hollatz, M. H., Chen, Z., Hochrein, L. M., Huang, J. & Pierce,
N. A. Conditional Guide RNAs: Programmable Conditional Regulation of
CRISPR/Cas Function in Bacterial and Mammalian Cells via Dynamic RNA
Nanotechnology. ACS Cent. Sci. doi:10 . 1021 / acscentsci . 9b00340
(2019).
M.H.H.-H. participated in cgRNA mechanism invention, exploratory mech-
anism studies, experimental design, and developing the data presentation ap-
proach, and performed computational sequence design for all splinted switch
and toehold switch mechanisms, computational sequence design for mam-
malian terminator switch mechanism, splinted switch and toehold switch
mechanism prototyping and optimization in bacteria, and all final data col-
lection in bacteria. Paper written by M.H.H.-H. and N.A.P. Supplementary
information written by M.H.H.-H., L.M.H. and N.A.P.
vii
TABLE OF CONTENTS
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iii
Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v
Published Content and Contributions . . . . . . . . . . . . . . . . . . . . . . vi
Table of Contents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
List of Illustrations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
List of Tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xii
Chapter I: Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1 Nucleic acid nanotechnology through the rational design of sequence
and structure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Small conditional RNAs for programmable conditional regulation . . 2
1.3 Programmable regulation with CRISPR/Cas . . . . . . . . . . . . . 4
1.4 Conditional guide RNAs . . . . . . . . . . . . . . . . . . . . . . . . 7
1.5 Thesis outline . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
Chapter II: Engineering orthogonal constitutively active cgRNAs in vitro via
hybridization of target sequence-independent modifications . . . . . . . . 9
Chapter III: Study of domain dimensioning for constitutively active sequence-
independent cgRNAs in E. coli . . . . . . . . . . . . . . . . . . . . . . . 19
Chapter IV: Engineering orthogonal constitutively active cgRNAs in E. coli
via hybridization of target sequence-independent modifications . . . . . . 27
4.1 Automated sequence design of orthogonal constitutively active splinted
switch cgRNAs using NUPACK . . . . . . . . . . . . . . . . . . . . 27
4.2 Performance of orthogonal constitutively active splinted switch cgR-
NAs in E. coli . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
4.3 Increasing fractional dynamic range of splinted switch cgRNAs . . . 36
4.4 Characterization of cgRNA temporal response with induction of cog-
nate trigger . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
Chapter V: Engineering orthogonal constitutively inactive cgRNAs in E. coli
via sequestration of the target binding region . . . . . . . . . . . . . . . . 41
Chapter VI: Conclusions and future directions . . . . . . . . . . . . . . . . . 48
6.1 Developing cgRNA mechanisms with improved dynamic range . . . 48
6.2 Detection of endogenous mRNA inputs with cgRNAs . . . . . . . . 51
6.3 Mechanismengineering for versatile constitutively inactive (OFF→ON)
cgRNAs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
6.4 Future applications for cgRNAs . . . . . . . . . . . . . . . . . . . . 52
Bibliography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
Appendix A: Materials and methods . . . . . . . . . . . . . . . . . . . . . . 63
A.1 Rational design of libraries of orthogonal cgRNAs using NUPACK . 63
A.2 In vitro assay of gRNA/cgRNA activity with catalytically active Cas9 65
A.3 Methods for bacterial studies in E. coli . . . . . . . . . . . . . . . . 65
viii
A.4 Part sequences for cgRNA, trigger, and control gRNA . . . . . . . . 72
A.5 Plasmids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
A.6 Sequences for dsDNA target . . . . . . . . . . . . . . . . . . . . . . 91
Appendix B: Supplementary figures and data for Chapter 2 . . . . . . . . . . 93
Appendix C: Supplementary figures and data for Chapter 3 . . . . . . . . . . 96
Appendix D: Supplementary figures and data for Chapter 4 . . . . . . . . . . 104
Appendix E: Supplementary figures and data for Chapter 5 . . . . . . . . . . 107
ix
LIST OF ILLUSTRATIONS
Number Page
1.1 Programmable conditional regulation . . . . . . . . . . . . . . . . . 4
1.2 Conditional guide RNA (cgRNA) . . . . . . . . . . . . . . . . . . . 5
2.1 In vitro assay of guide RNA (gRNA) activity . . . . . . . . . . . . . 10
2.2 Constitutively active cgRNAs (ON→OFF logic) with catalytically
active Cas9 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
2.3 Target test tubes for sequence design of splinted switch cgRNAs with
15 nt sequence inserts . . . . . . . . . . . . . . . . . . . . . . . . . 12
2.4 Study of the effect of 15 nt 5′ extension and handle loop sequence
inserts on guide RNA activity in vitro . . . . . . . . . . . . . . . . . 13
2.5 Programmable conditional function of four orthogonal splinted switch
cgRNAs in vitro . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.6 In vitro cgRNA mechanism function with Cas9 pre-incubation . . . . 16
2.7 Programmable conditional function of four orthogonal 15 nt insert
splinted switch cgRNAs with silencing dCas9 in E. coli . . . . . . . 18
3.1 Logic and schematic for single and double sequence inserts for con-
struction of allosteric cgRNAs in E. coli . . . . . . . . . . . . . . . . 19
3.2 Target test tubes for sequence design of candidate single and double
sequence insert cgRNAs . . . . . . . . . . . . . . . . . . . . . . . . 21
3.3 Performance of single and double sequence inserts for construction
of allosteric cgRNAs in E. coli . . . . . . . . . . . . . . . . . . . . . 23
3.4 Fractional dynamic range vs predicted ∆∆G of trigger binding for
candidate cgRNAs with handle loop insert . . . . . . . . . . . . . . 26
4.1 Constitutively active splinted switch cgRNAs (ON→OFF logic) with
silencing dCas9 in E. coli . . . . . . . . . . . . . . . . . . . . . . . 28
4.2 Target structure definition and nucleotide defect weights for sequence
design of splinted switch cgRNAs . . . . . . . . . . . . . . . . . . . 30
4.3 Target test tubes for sequence design of orthogonal splinted switch
cgRNAs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
4.4 Analysis of design quality by equilibrium pair probability . . . . . . 33
4.5 Computational orthogonality study for splinted switch design. . . . . 34
x4.6 Characterization of ON state of four orthogonal splinted switch cgR-
NAs in E. coli . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
4.7 Programmable conditional function of three orthogonal splinted switch
cgRNAs (ON→OFF logic) with silencing dCas9 in E. coli . . . . . . 36
4.8 Characterization of splinted switch performance with lacI-regulated
expression of no-target gRNA competitor . . . . . . . . . . . . . . . 38
4.9 Characterization of splinted switch response to lacI-regulated trigger
expression in E. coli . . . . . . . . . . . . . . . . . . . . . . . . . . 40
5.1 Constitutively inactive toehold switch cgRNAs (ON→OFF logic)
with silencing dCas9 in E. coli . . . . . . . . . . . . . . . . . . . . . 42
5.2 Target test tubes for sequence design of orthogonal toehold switch
cgRNAs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
5.3 Characterization of ON state of four orthogonal toehold switch cgR-
NAs in E. coli . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
5.4 Programmable conditional function of three orthogonal toehold switch
cgRNAs (OFF→ON logic) with silencing dCas9 in E. coli . . . . . . 45
5.5 Characterization of toehold switch cgRNAwith varied trigger domain
dimensions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
A.1 Example plasmid map for splinted switch in E. coli . . . . . . . . . . 84
A.2 Example annotated plasmid sequence for splinted switch in E. coli . . 85
A.3 Example plasmid map for toehold switch in E. coli . . . . . . . . . . 87
A.4 Example annotated plasmid sequence for toehold switch in E. coli . . 88
A.5 Plasmid map for pdCas9+lacI in E. coli . . . . . . . . . . . . . . . . 89
A.6 Annotated plasmid sequence for expression of pdCas9+lacI in E. coli 90
B.1 Quantifying in vitro cgRNA insert study (cf. Figure 2.4) . . . . . . . 93
B.2 Additional reaction conditions and quantification of in vitro cgRNAs 94
C.1 Fractional dynamic range vs predicted ∆∆G of trigger binding for all
single and double insert candidate cgRNAs . . . . . . . . . . . . . . 103
D.1 Analysis of design quality by equilibrium pair probability for splinted
switch cgRNA:trigger XA duplex . . . . . . . . . . . . . . . . . . . 104
D.2 Flow cytometry replicates for splinted switch ON state, OFF state,
and conditional response in E. coli . . . . . . . . . . . . . . . . . . . 105
D.3 Flow cytometry replicates for splinted switch orthogonal response in
E. coli . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
E.1 Flow cytometry replicates for toehold switch ON state, OFF state,
and conditional response in E. coli . . . . . . . . . . . . . . . . . . . 107
xi
E.2 Flow cytometry replicates for toehold switch orthogonal response in
E. coli . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
xii
LIST OF TABLES
Number Page
A.2 Splinted switch sequences for in vitro studies (Chapter 2) . . . . . . . 73
A.4 Candidate cgRNA/trigger sequences for insert studies in E. coli
(Chapter 3) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
A.5 Splinted switch sequences for studies in E. coli (Chapter 4) . . . . . . 80
A.6 Toehold switch sequences for studies in E. coli (Chapter 5) . . . . . . 81
A.7 Control gRNA sequences . . . . . . . . . . . . . . . . . . . . . . . . 81
A.8 Transcriptional promoter and terminator sequences . . . . . . . . . . 82
A.9 Plasmids used with splinted switch cgRNAs in E. coli . . . . . . . . 83
A.10 Plasmids used with toehold switch cgRNAs in E. coli . . . . . . . . . 86
C.1 Quantifying ON state, OFF state, fold change, and dynamic range for
gRNA insert studies, 0.2 nM aTc . . . . . . . . . . . . . . . . . . . . 97
C.2 Quantifying ON state, OFF state, fold change, and dynamic range for
gRNA insert studies, 2 nM aTc . . . . . . . . . . . . . . . . . . . . . 99
C.3 Quantifying ON state, OFF state, fold change, and dynamic range for
gRNA insert studies, 20 nM aTc . . . . . . . . . . . . . . . . . . . . 101
C.4 Free energy of cgRNA/trigger complexes and trigger hybridization
for candidate cgRNAs with single and double inserts predicted via
NUPACK analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
D.1 Quantifying ON state, OFF state, fold change, and dynamic range for
splinted switch cgRNA in E. coli . . . . . . . . . . . . . . . . . . . . 105
D.2 Quantifying crosstalk for cognate and non-cognate splinted switch
cgRNA/trigger pairs in E. coli . . . . . . . . . . . . . . . . . . . . . 106
E.1 Quantifying ON state, OFF state, fold change, and dynamic range for
toehold switch cgRNA in E. coli . . . . . . . . . . . . . . . . . . . . 107
E.2 Quantifying crosstalk for cognate and non-cognate toehold switch
cgRNA/trigger pairs in E. coli . . . . . . . . . . . . . . . . . . . . . 108
1C h a p t e r 1
INTRODUCTION
The nucleic acids DNA and RNA are central to the function of all known forms of
life. In their information-bearing role, DNA and RNA serve to store and transmit
the genetic information characteristic of a particular cell. The information encoded
in these nucleic acids also directs the fate of the individual cell, as both the template
for gene expression and, for RNA, through the control of gene expression via various
regulatory pathways. In this way, the identity of the nucleic acid species within a
cell is both indicative of its current state and a determinant of its future. To have at
our disposal a general and versatile means for the coupled detection of intracellular
nucleic acids and generation of biologically active nucleic acid species is to be fluent
in the language of the cell’s internal environment. The motivating goal of the work
presented here is to contribute to the development of such a means, leveraging recent
progress in the engineering of dynamic nucleic acid nanotechnology through rational
design and our ability to affect gene expression using CRISPR/Cas technology.
1.1 Nucleic acid nanotechnology through the rational design of sequence and
structure
The same information-bearing capacity and reliable base-pairing essential to the
natural biological role of nucleic acids have been essential to the field of nucleic
acid nanotechnology, in which these properties are exploited to precisely engineer
the structure and dynamics of RNA and DNA. Rational design of DNA sequence
has enabled the sequence-guided self-assembly of static 2- and 3-dimensional DNA
nanostructures, based on the hierarchical assembly of small DNA tiles1–5 or the
sequence-guided folding of much larger DNA scaffolds into DNA origami struc-
tures on the scale of 100 nanometers,4–7 the latter providing addressability of
specific sites on structures of arbitrary geometry with sub-nanometer resolution in
some cases.8,9 The relatively diverse set of RNA secondary and tertiary structural
motifs has provided a basis for the design of self-assembled static 2D and 3D RNA
architectures,10–14 including the cotranscriptional folding of RNA tiles for higher-
order assembly15 and the in vivo production of RNA nanostructures16,17 which
highlight the ability to transcribe RNA within a cell as a potential advantage of
engineered RNA structures for in vivo applications. Dynamic interactions of nu-
2cleic acid species have also been engineered, largely based on strand displacement
via toehold-mediated branch migration.18–20 Examples include DNA motors,21–23
computation with DNA logic gates,24–26 and signal amplification via programmed
polymerization,27–29 among others.19,20,30,31
The rational design of nucleic acid structure and dynamics has been facilitated by ad-
vancements in algorithms for the prediction and design of DNA and RNA secondary
structure. Dynamic programming algorithms have been developed for the calcula-
tion of the partition function of a given sequence over all secondary structures, and
hence the equilibrium base pairing probabilities for a single strand32,33 and, further,
complexes of interacting strands34,35 and test tubes of interacting strands36,37 using
a physical model based on experimentally derived energy parameters.38–40 These
same in silico analytical methods can be extended to the design of de novo nucleic
acid sequence to adopt a particular target structure within a structural ensemble.33,35
Design algorithms have subsequently been extended to the design of a test tube
of complexes with specified target concentrations36 and, most recently, the abil-
ity to design nucleic acid reaction pathways with a set of target test tubes, each
with their own target structures and concentrations and subject to diverse sequence
constraints.37 This paradigm of sequence optimization through prediction of nu-
cleic acid secondary structure has been implemented for the design of a number of
dynamic RNA structures, including riboswitches,41 sets of orthogonal conditional
activators of transcription42 and translation43 in bacteria, and partially chemically
modified RNA mechanisms for the conditional generation of Dicer substrates.44,45
1.2 Small conditional RNAs for programmable conditional regulation
To date, dynamic DNA nanotechnology in a test tube19,30 has received far more re-
search emphasis than dynamic RNA nanotechnology in the cell,42,46–48 although it
is the latter that has the greatest potential for introducing synthetic regulatory links
into living cells and organisms. We envision small conditional RNAs (scRNAs)
that, upon detection of a programmable nucleic acid input, change conformation to
produce a programmable output that up-regulates or down-regulates the activity of
a biological pathway. In this scenario, the input controls the scope of regulation and
the output controls the target of regulation, with the scRNA performing signal trans-
duction to create a logical link between the two. Any pathway that recognizes RNA is
a potential candidate for conditional regulation by scRNAs (e.g., RNA interference,
RNase H, PKR, RIG-1, endosomal TLRs, CRISPR/Cas), as these pathways provide
a built-in infrastructure for producing the downstream biological effect for which we
3can potentially engineer a conditionally active substrate. Several groups have made
contributions toward the goal of conditional regulation via the RNA interference
pathway, with demonstrations of nucleic acid-triggered conditional generation of
siRNAs49 and Dicer substrates.44,45,50–52 scRNA mechanisms developed in our lab
toward the goal of conditional RNA interference (RNAi) have been demonstrated
in buffer44 and human cell lysate,45 the simplest consisting of a dimer scRNA that
conditionally generates a monomer Dicer substrate anti-Y upon detection of mRNA
X. CRISPR/Cas9 is another RNA-recognizing pathway which has seen significant
recent development and broad application,53 and as such is an attractive candidate
for the implementation of conditional regulation.
With the ubiquity of nucleic acid species as potential inputs and the diversity of
downstream biological effects of RNA-recognizing pathways, the potential applica-
tions of a robust and versatile scRNA implementation would be far-reaching. Ex-
isting methods for programmable regulation of gene expression (e.g., CRISPR/Cas,
RNAi) enable the selection of gene target Y as the sequence-specific target of a
regulatory pathway, but lack a general means to restrict regulation to a desired lo-
cation and time (Figure 1.1, top arrow; all cells are subject to the same downstream
regulation of target Y). In principle, scRNAs could restrict activity of a regula-
tory pathway to a desired cell type, tissue, or organ by selecting an endogenous
RNA trigger X with the desired spatial and temporal expression profile (Figure
1.1, bottom arrow), independent of the downstream target Y. To shift conditional
regulation to a different tissue or developmental stage, the scRNA would simply
be reprogrammed to recognize a different trigger sequence, providing a powerful
tool for fundamental biological study. This same approach to signal transduction
would also have attractive therapeutic potential, with trigger X as a programmable
disease marker and target Y as an independent programmable therapeutic target,
enabling selective treatment of diseased cells. Synthetic biology provides another
attractive arena for use of scRNAs. Traditional synthetic biology regulators have re-
lied on protein:protein and protein:DNA interactions mined from existing genomes,
placing limits on scalability due to crosstalk and the limited number of available
regulators.54,55 With powerful tools for rational design and a large sequence space
for the design of orthogonal libraries of interoperable parts, scRNA regulators offer
a promising platform for scalable synthetic biology.
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regulation
(not Y)
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(if X then not Y)
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X and Y expressed
Figure 1.1: Programmable conditional regulation. Molecular logic of pro-
grammable regulation using a standard programmable regulator, such as
CRISPR/Cas gRNA (“not Y,” top arrow) vs programmable conditional regulation
using a small conditional RNA, such as a cgRNA (“if X, then not Y,” bottom arrow).
In this conceptual illustration, the standard programmable regulator silences Y in
all tissues, while the programmable conditional regulator silences Y only in tissues
where and when X is expressed, exerting spatiotemporal control over regulation.
1.3 Programmable regulation with CRISPR/Cas
CRISPR/Cas systems exists in nature as a prokaryotic immune system, enabling
nucleic acid sequence-specific acquired immunity to foreign genetic elements.56–58
Although varied in their mechanisms of adaptation, guide RNA (gRNA) structure
and biogenesis, and the identity of their interference proteins, the foundation of
all CRISPR/Cas interference is the targeting of foreign nucleic acids by RNA-
guided CRISPR nucleases.57–59 The specificity of the interaction between the guide
RNA/CRISPR effector complex and the nucleic acid target is dependent on the
variable sequence of nucleotides in the gRNA target-binding region and on the
presence of a protospacer adjacent motif60 (PAM, or, alternatively, a protospacer
flanking site61), a short CRISPR effector-specific sequence adjacent to the target
sequence in the nucleic acid target58 (Figure 1.2a). The gRNA may be a single
strand or complex of strands, with a programmable target binding region and a
CRISPR effector-specific structure and sequence preference.58,60
The repurposing of RNA-guided CRISPR effectors through the development of
modified gRNAs and CRISPR-associated (Cas) proteins has yielded a suite of pow-
erful tools for biological research and synthetic biology.53,62 A notable property of
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Figure 1.2: Conditional guide RNA (cgRNA). (a) A standard guide RNA (gRNA)
directs the function of protein effector dCas9 to a target gene Y. (b) Standard guide
RNAs are constitutively active, lacking a general means for spatiotemporal control;
different dCas9 variants implement different functions (edit, silence, induce, bind).
(c) A conditional guide RNA (cgRNA) changes conformation in response to a
programmable trigger X to conditionally direct the activity of a protein effector
to a programmable target Y. Top: a constitutively active cgRNA is conditionally
inactivated by triggerX (ON→OFF logic). Bottom: a constitutively inactive cgRNA
is conditionally activated by trigger X (OFF→ON logic).
6Cas9, the most studied of the Class 2 CRISPR effectors,63 is its portability between
species, with the same basic architecture applied to gene editing in a diverse array
of cell types and organisms.63,64 Precision genome editing has been achieved in
a variety of organisms using gRNAs to direct the nuclease activity of Cas9 and
Cas12a (Cpf1) to a target gene of choice.53,65–67 Mutation of the nuclease domains
to produce a catalytically dead Cas9 (dCas9) has enabled silencing of genetic ex-
pression via inhibition of transcriptional elongation,68,69 or induction (or silencing)
of genetic expression using dCas9 fusions that incorporate transcriptional regula-
tory domains.70 Similarly, the function of several sub-types of the RNA-targeting
CRISPR effector Cas13 (c2c2) has been demonstrated for the highly specific knock
down of RNA in human and plant cells,71–74 and the development of catalytically
dead Cas13 has enabled site-specific RNA editing73 and modulation of RNA splic-
ing.71,75,76 Other dCas9 fusions have mediated target-binding to enable visualization
of genomic loci,77,78 epigenetic modification,79 and single-base editing at a specific
genomic locus.53,80 Hence, gRNA:effector complexes combine the benefits of the
rich functional vocabulary of the protein effector (edit, silence, induce, bind) and
the programmability of the gRNA in targeting effector activity to a gene of choice.
The functional versatility, high regulatory dynamic range, and portability between
species characteristic of the pathway53,68,70 position CRISPR/Cas9 as a particu-
larly suitable regulatory motif for the development of novel and diverse modes of
programmable conditional regulation in living organisms.
Because gRNAs are constitutively active (Figure 1.2b), additional measures are
needed to restrict effector activity to a desired location and time.81 Temporal control
can be achieved by small-molecule induction of gRNAs82,83 or Cas9,84 but this
comes with limitations in terms of multiplexing and spatial control. Spatiotem-
poral control has been achieved by regulation of Cas9 via photoactivation85 or
via tissue-specific promoters or microRNAs,86–88 which come with the unwelcome
restriction that all gRNAs are subject to the same regulatory scope and lack the
versatile programmability possible with the scRNA paradigm. Systematic map-
ping of the structure and sequence properties of functional gRNAs has revealed
that Cas9 activity is tolerant to significant modifications to the standard gRNA
structure,89,90 facilitating introduction of auxiliary domains that enable conditional
control of gRNA activity via structural changes induced by small-molecules,91–93
protein-bound RNAs,94 nucleases,95 or nuclease-recruiting DNAs.95 Alternatively,
the activity of standard gRNAs has been modulated by antisense RNAs96 or by pho-
tolysis of antisense DNAs incorporating photocleavable groups.97 For generality,
7it is highly desirable to control the regulatory scope in a manner that is both con-
ditional and programmable, a tantalizing prospect central to the proposed scRNA
paradigm based on dynamic RNA nanotechnology.
1.4 Conditional guide RNAs
With this paradigm for programmable conditional regulation in mind, we set out
to engineer conditional guide RNAs (cgRNAs, a class of scRNA) that change con-
formation in response to an RNA trigger X to conditionally direct the function
of dCas9 to a target gene Y (Figure 1.2c). Unlike a standard gRNA, a cgRNA
is programmable at two levels, with the trigger-binding sequence (constrained by
trigger X) controlling the scope of cgRNA activity and the target-binding sequence
(constrained by target Y) determining the subject of effector activity. Functionally,
the cgRNA must perform sequence transduction between X and Y as well as shape
transduction between active/inactive conformations. In principle, the activity of
a single-input cgRNA can be engineered to be toggled either OFF→ON (as was
recently demonstrated by Siu and Chen with dCas998 and Oesinghaus and Simmel
with dCas12a99) or ON→OFF in response to a cognate RNA trigger X; this condi-
tional control can be exerted over dCas9 variants that either edit, silence, induce, or
bind the target Y, emphasizing the broad functional potential available via interplay
between cgRNA logic and protein effector function (Figure 1.2c).
To implement the conditional logic of cgRNAs, it is essential to modify the sequence
and structure of the standard guide RNA in away that is well tolerated in the ON state
(i.e., minimally disrupts the formation of the gRNA:dCas9 complex and downstream
interaction with target Y when ON), and provides a basis for a clean OFF state (i.e.,
is structurally incompatible with the formation of the gRNA:dCas9 complex and/or
downstream interaction with target Y when OFF). Prior to our lab’s work on cgRNA
engineering, there had been no literature reports of the systematic study of the
sequence and structural modifications to the standard gRNA required for toggling
CRISPR/Cas activity (ON→OFF or OFF→ON) in response to hybridization of a
nucleic acid trigger. However, anecdotal reports of the incorporation of sequence
domains to recruit various binding proteins66,100–104 and of aptamer modifications
achieving a conditional response to the presence of small molecules91–93 provide us
some insight into which regions of the gRNA might best tolerate the incorporation
of new sequence (notably, the handle hairpin loop,100,102–106 the first terminator loop
of the S. pyogenes terminator,100,102–106 and, in the mammalian setting, the 3’ end of
the gRNA66,91,100–102,105). Partial tolerance of gRNA activity to target-mismatched
8nucleotides in an extended target-binding region66,69 point to a 5’ extension of
the gRNA as another promising prospect. Crystal structures of the gRNA:Cas9
complex indicate that these same regions are solvent exposed,107–110 and as such are
strong candidates for modifications tolerated in the ON state, as inserted nucleic acid
sequence might minimally disrupt the structure of Cas9. Systematic study of the
sequence and structural requirements for a functional guide RNA60,89,90,111–113 also
provide us insight into the gRNA structural components most sensitive to disruption,
and as such guide mechanism design for achieving the desired OFF state.
1.5 Thesis outline
The chapters that follow detail the work I have done toward the goal of implementing
programmable conditional regulation using CRISPR/Cas9, both in vitro and in
bacteria. Chapter 2 details the engineering of cgRNAs and the development of a
set of sequence-independent ON→OFF orthogonal regulators in vitro. Chapter 3
describes a systematic study of the modification of gRNA sequence and structure
motivated by the failure of the aforementioned in vitro cgRNAs when tested in
E. coli. Chapter 4 describes the study of the constitutively active (ON→OFF)
splinted switch cgRNAmechanism (identified through the systematic study of gRNA
modification ofChapter 3) and the demonstration of a set of orthogonal constitutively
active cgRNAs in E. coli, with a more detailed discussion of the tools used for
cgRNA design. Chapter 5 introduces a cgRNA mechanism of the inverse logic
(constitutively inactive, OFF→ON) and details the performance of an orthogonal
set of these constitutively inactive cgRNAs in E. coli. Chapter 6 summarizes the
major contributions of this work, and discusses future work that will be required
to develop cgRNAs into a robust and versatile tool for programmable conditional
regulation.
Materials andmethods for Chapters 2–5 are provided inAppendixA. Supplementary
figures and data for the results and discussion presented in Chapters 2–5 are included
in Appendices B–E.
9C h a p t e r 2
ENGINEERING ORTHOGONAL CONSTITUTIVELY ACTIVE
cgRNAS IN VITRO VIA HYBRIDIZATION OF TARGET
SEQUENCE-INDEPENDENT MODIFICATIONS
To enable the study of candidate modifications to the sequence and structure of
the standard Cas9 gRNA, and to subsequently demonstrate the conditional and
orthogonal performance of the cgRNA mechanisms we design, we developed an
assay for gRNA activity in vitro (Figure 2.1). Although removed from our ultimate
goal of conditional regulation in living cells, an in vitro assay of gRNA activity
provides the opportunity to study gRNA and cgRNA performance without the
potentially confounding factors ofmetabolism, unknown absolute quantity of system
components, and the influence of unintended off-target interactions. The reaction
mixture contains only those components essential to the assay of gRNA activity—
namely the gRNA itself (in vitro transcribed and purified), recombinantCas9 protein,
and dsDNA target containing a single target binding site with adjacent PAM—
and buffer. The activity of the gRNA can be assayed through the visualization
and quantification of the dsDNA cleavage products via non-denaturing PAGE with
a nucleic acid stain, as the sequence-guided cleavage of the dsDNA target (into
two fragments of known size) reflects the capacity of the gRNA to mediate the
interaction between catalytically active Cas9 and dsDNA target. This assay also
enables visualization of nucleic acid interactions (hybridization states of nucleic
acid species), such as the homodimer band visible in the gRNA+Cas9 lane of
Figure 2.1, thereby enabling direct observation of both the mechanism of action of
candidate cgRNAs (i.e., hybridization of cgRNA and trigger via the associated shift
in mobility) and any unintended hybridization interactions or crosstalk.
Motivated by the reported tolerance gRNAactivity to handle loopmodifications100,102–106
and 5′ extension66,69 in vitro, and the essential roles of the gRNA target binding
region and handle region for gRNA interaction with target60 and Cas9,89,107,109 re-
spectively, we designed a constitutively active cgRNAmechanism for the conditional
cleavage of dsDNA target Y by catalytically active Cas9 (Figure 2.2a). Compared
to a standard gRNA (Figure 1.2a), this “splinted switch” mechanism has a rationally
designed 15 nt 5′ extension domain “d” and modified handle with a designed 15 nt
extended loop domain “e” (Figure 2.2b). Hybridization of the RNA trigger X to
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Figure 2.1: In vitro assay of guide RNA (gRNA) activity. Functional in vitro
transcribed gRNA directs catalytically active recombinant Cas9 to a single target
sequence within a purified dsDNA target, resulting in cleavage of the dsDNA. The
extent of dsDNA target cleavage can be assayed via non-denaturing PAGE (4-20%
1xTBE polyacrilimide gel).
these modified domains is intended to form a structure incompatible with cgRNA
mediation of Cas9 function by sequestering the target binding region of the gRNA
and disrupting the handle structure.
RNA trigger X
d* e*
Target dsDNA Y 
...... u*
u
a
b
In vitro splinted switch cgRNA  (ON   OFF logic) 
ON State OFF State
Constitutively
Active
cgRNAX Y
recombinant Cas9
 cleavage
cgRNA
d
e
u
cgRNA:trigger
d
e
d*e*u
Figure 2.2: Constitutively active cgRNAs (ON→OFF logic) with catalytically active
Cas9. (a) Conditional logic: if not X, then not Y. (b) cgRNA mechanism: the
constitutively active cgRNA is inactivated by hybridization of RNA trigger X.
Rational sequence design of the 15 nt 5′ extension (domain “d”) and an extended 15
nt Cas9 handle loop (domain “e”).
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A set of four orthogonal cgRNA/trigger sequences was designed using the reac-
tion pathway designer within NUPACK.35,37 Sequence design was formulated as
a multistate optimization problem using target test tubes to represent reactant and
product states of cgRNA/trigger hybridization, as well as to model crosstalk between
orthogonal cgRNA/trigger pairs (Figure 2.3). Note that the trigger target structure
XN contains a hairpin with sequence constrained by synthetic terminator at its 3′
end; anticipating the potential for future implementation in living cells, cgRNAs
were designed with a previously characterized68 sfGFP target-binding region, and
triggers designed with a synthetic transcriptional terminator for expression in E.
coli. Each reactants tube (Figure 2.3, Step 0G and Step 0X) and products tube (Step
1) contains a set of desired “on-target” complexes (each with a target secondary
structure and target concentration) corresponding to the on-pathway hybridization
products for a given step, and a set of undesired “off-target” complexes (each with
a target concentration of 0 nM) corresponding to on-pathway reactants and off-
pathway hybridization crosstalk for a given step. Hence, these elementary step
tubes are designed for full conversion of cognate reactants into cognate products
and against local hybridization crosstalk between these same reactants. To simul-
taneously design N orthogonal systems, elementary step tubes are specified for
each system (Figure 2.3; left). Note that for design of a library of N orthogonal
cgRNA/trigger pairs, all N cgRNAs have the same on-target structure, and all N
triggers have the same on-target structure; within a library, the only difference be-
tween cgRNA/trigger pairs is the designed sequence. To design against off-pathway
interactions between systems, a set of crosstalk tubes are specified (Figure 2.3;
right), with each noncognate pair defined explicitly as its own tube. This design
used a version of NUPACK that did not yet support exclusion of a set of user-defined
complexes from a target test tube ensemble; a more compact specification to design
against off-pathway interactions between systems utilizing the exclusion of com-
plexes with NUPACK 3.2 (as implemented byWolfe et al.37) is described in Chapter
3 and in Section 4.1.
As a first step to characterize this cgRNA mechanism, we sought to confirm that
the designed 15 nt 5′ extension and handle loop sequences were compatible with
interactions between cgRNA, Cas9, and target in the cgRNA ON state (i.e., cgRNA
in the absence of trigger). DNA templates were constructed for each 15 nt insert
(viz. 5′ extensions and handle loops A, B, C, and D) and each double-modification
cgRNA (cgRNAs A, B, C, and D), and from these templates candidate cgRNAs
were in vitro transcribed and PAGE purified. Assaying the activity of each of these
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Figure 2.3: Target test tubes for sequence design of splinted switch cgRNAs with
15 nt sequence inserts. Top: Target test tube schematics. Bottom: Target test tube
details. Each target test tube contains the depicted on-target complexes (each with
the depicted target structure and target concentration) and the off-target complexes
listed in the table (eachwith vanishing target concentration). The on-target structures
depicted above are used in the mechanism schematic of Figure 2.2, with the addition
of a short synthetic trigger terminator for future E. coli studies. To simultaneously
design N orthogonal systems, the total number of target test tubes is |Ω| = N2 +2N .
Lmax = 2 for all tubes. Design conditions: RNA in 1 M Na+ at 37 ◦C.38
candidate cgRNAs in vitro, we observed cgRNA-mediated cleavage of dsDNA target
by all single- and double-modified cgRNAs (Figure 2.4a), with yield comparable to
that of the standard (unmodified) gRNA (Figure 2.4b).
To achieve the desired OFF state, we hope to observe a high yield of cgRNA:trigger
duplex through hybridization of the cognate trigger with the designed sequence
domains. An in vitro assay of cgRNA activity in the absence and presence of cognate
trigger produced a visible shift in the cgRNA band with both a 2x (Figure B.2) and
10x (Figure 2.5a) excess of trigger, indicating formation of the cgRNA:trigger duplex
as intended. Further, a significant reduction in cleavage is observed in the presence
of cognate trigger (dark magenta boxes in Figure 2.5a), achieving a conditional
ON→OFF response for each of the four cgRNAs, with OFF state comparable to the
ideal OFF state given by a control reaction lacking gRNA (Figure 2.5b, left).
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Figure 2.4: Study of the effect of 15 nt 5′ extension and handle loop sequence
inserts on guide RNA activity in vitro. (a) Non-denaturing PAGE (4-20% 1xTBE
polyacrilimide gel) of reaction products for each of four sequences (A, B, C, and
D) of 5′ extension, handle loop insert, and combined 5′ extension and handle
loop insert (15 nt each). (b) Quantification of normalized mean pixel intensity for
each candidate cgRNA (modified guide RNA) using dsDNA cleavage fragment 1.
Normalized mean intensity = [(mean fragment 1 band intensity) - background]/[(no
gRNA mean fragment 1 band intensity) - background]. Observed cleavage activity
for each of the candidate cgRNAs tested is comparable to that of the standard gRNA,
indicating all modifications arewell tolerated in theON state. dsDNA target contains
a single 20 nt target binding sequence from sfGFP, and the adjacent PAM sequence
[AGG].
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Figure 2.5: Programmable conditional function of four orthogonal splinted switch
cgRNAs in vitro. (a) Non-denaturing PAGE (4-20% 1xTBE polyacrilimide gel) of
reaction products for four cgRNAs (A, B, C, and D) with each of four synthetic
RNA triggers (XA, XB, XC , and XD). cgRNA was snap-cooled with RNA trigger
in buffer and pre-incubated with recombinant Cas9 (10 min) prior to addition of
dsDNA target (final reaction concentrations: 30 nM cgRNA, 300 nM RNA trigger,
3 nM dsDNA cleavage target). Cleavage fragment with cognate trigger indicated
by dark magenta boxes, cleavage fragment with noncognate trigger indicated by
green boxes. All lanes include Cas9 and dsDNA target. (b) Left: Quantification of
normalized mean pixel intensity for each cgRNAwith and without RNA trigger (see
full nucleic acid gels, Figure B.2) using dsDNA cleavage fragment 1. Normalized
mean intensity = [(mean fragment 1 band intensity) - background]/[(no gRNAmean
fragment 1 band intensity) - background]. Right: normalized intensity depicting
orthogonality between noncognate cgRNA/trigger pairs (crosstalk = [(noncognate
trigger) - (no trigger)]/[(cognate trigger) - (no trigger)]; crosstalk for cognate trigger
= 1 by definition).
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With this splinted switch mechanism, the sequences of the RNA trigger X and
the silencing target Y are fully independent, with the cgRNA mediating allosteric
regulation: the trigger down-regulates cgRNA:Cas9 activity not by sequestering
the target-binding region (orange in Figure 2.2b), but by hybridizing to the distal
trigger-binding regions (blue). Toward the goal of developing a versatile means
of programmable conditional regulation, this sequence-independence of X and Y
is a distinct asset for programmability, as trigger X and target Y can be selected
and reassigned independently, improving potential outcomes for the design of or-
thogonal regulators and allowing the possibility to select X and/or Y from endoge-
nous biological sequences. To test the programmability of this mechanism, we
assayed the activity of each of the four cgRNAs with its cognate trigger and each
of three noncognate triggers, achieving a median ≈6% crosstalk for noncognate
cgRNA/trigger combinations (Figure 2.5b, right). Although significant crosstalk is
observed for cgRNA C with triggers XA and XB, the strong ON state, substantial
ON→OFF response in the presence of trigger, and low median crosstalk of this
mechanism in vitro affirm its potential as a candidate for conditional programmable
regulation in living cells.
At present, it is unclear if the OFF state is achieved by a cgRNA:trigger duplex
incompatible with Cas9 binding, a cgRNA:trigger:Cas9 triplex incompatible with
dsDNA target localization, or a cgRNA:trigger:Cas9:dsDNA quadruplex that dis-
rupts the nuclease function of Cas9 (or a combination of partial contributions of
the above). In working toward the implementation of cgRNAs for conditional reg-
ulation in living cells, in vitro study may prove useful in the elucidation of the
structural details of the cgRNA OFF state, and the mechanism by which the cgRNA
is toggled between states. It also remains to measure and optimize cgRNA condi-
tional response times, which are expected to depend on a variety of factors, including
whether trigger can toggle the state of both free cgRNA and cgRNA in complex with
Cas9 (possibly a mechanism-specific property), and, in living cells, the production
and degradation rates of the participating chemical species. As an initial effort to
investigate the accessibility of the cgRNA to trigger when bound by Cas9 (i.e., in the
cgRNA:Cas9 complex), and hence our ability to toggle the cgRNA from ON to OFF
when already in the presence of effector, we assayed gRNA- and cgRNA-mediated
cleavage of dsDNA target under a variety of conditions, varying the relative times
at which Cas9, trigger, and dsDNA target were introduced into the reaction mixture
(Figure 2.6). When a short target-binding region antisense trigger was annealed with
a standard gRNA prior to the addition of Cas9 (Figure 2.6a, standard gRNA trigger
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Figure 2.6: In vitro cgRNA mechanism function with Cas9 pre-incubation. (a)
Non-denaturing PAGE (4-20% 1xTBE polyacrilimide gel) of reaction products for
standard gRNA and cgRNA in the absence of trigger and with trigger added under
varying conditions. Standard gRNA or cgRNA, recombinant Cas9, synthetic RNA
trigger, and dsDNA target were added to the reaction mixture at the times specified,
with t = 0 corresponding to the reaction start with dsDNA target addition (if
applicable) and incubation at 37 ◦C. Trigger was either omitted (trigger condition
0), snap-cooled with (c)gRNA for 5 min prior to the addition of Cas9 (trigger
condition I), added simultaneously with dsDNA target after a 10 min pre-incubation
of (c)gRNA with Cas9 (trigger condition II), or added 10 min before dsDNA target
after a 10 min pre-incubation of (c)gRNA with Cas9 (trigger condition III). A
synthetic 20 nt RNA complement to the target-binding region was used as trigger
for the standard gRNA. (b) Quantification of normalized mean pixel intensity for
standard gRNA and cgRNA in the absence of trigger and with trigger added under
varying conditions. Normalized mean intensity = [(mean fragment 1 band intensity)
- background]/[(no gRNAmean fragment 1 band intensity) - background]. Addition
of trigger to standard gRNA after incubationwith Cas9 appears to reduce the efficacy
of the trigger in producing the OFF state, whereas for cgRNA the trigger efficacy is
unaffected by Cas9 pre-incubation.
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condition I), we observed a significant decrease in target cleavage as compared to
the gRNA-only condition (condition 0). With a 10 min pre-incubation of gRNA and
Cas9, followed by the simultaneous addition of antisense trigger and dsDNA target
(condition II), we observed a notable increase in cleavage, i.e., a reduced effect of
the antisense trigger. When a 10-minute delay was introduced between the addition
of trigger to pre-incubated gRNA+Cas9 and the addition of dsDNA target (condition
III), this effect was partially mitigated. Unlike the standard gRNA, when a cgRNA
was pre-incubated with Cas9, no reduction in trigger efficacy was observed (Figure
2.6b, cgRNA trigger conditions II, III). This suggests that cgRNA accessibility to
trigger hybridization is not meaningfully impacted by its interaction with Cas9 in
this setting, possibly due to the probable solvent exposure of the 5′ extension and
extended handle loop with cgRNA bound by Cas9,107,109 further suggesting the
potential to achieve fast response times using this mechanism (on the timescale of
hybridization, rather than degradation and expression, in vivo).
Having demonstrated the programmable conditional function and orthogonality for
our library of four cgRNAs in vitro, we next investigated the function of this mech-
anism in living bacterial cells. We sought to validate the cgRNA mechanism in
E. coli expressing a fluorescent protein reporter (mRFP) as the target gene for si-
lencing via inhibition of transcriptional elongation by dCas9.68 In this setting, an
E. coli strain expressing the standard gRNA exhibits low fluorescence (ideal ON
state) while a strain expressing a no-target gRNA lacking a target-binding region
exhibits high fluorescence (ideal OFF state). For the cgRNAs in E. coli, we did
not observe a consistent effect on fluorescence due to the presence or absence of
a constitutively expressed cognate trigger (Figure 2.7, left), and there was no ob-
served selectivity for cognate trigger (Figure 2.7, right). These data lead to the
conclusion that in this in vivo setting, the set of four cgRNAs shown to function
conditionally and orthogonally in vitro do not function as intended. There exist
many plausible explanations for this difference in performance, including environ-
mental differences (such as molecular crowding114 and salt conditions115) resulting
in critically different binding energies for species involved, the unknown absolute
quantity and unreliable stoichiometry of those species, and a fundamental difference
in the downstream function of Cas9—namely, the difference between target cleavage
by catalytically active dCas9 and inhibition of transcriptional elongation by catalyt-
ically dead dCas9, the former being more sensitive to the binding of the 5′-most
bases of the target-binding region,116,117 suggesting potential for a “cleavage-only”
cgRNA mechanism. The genesis of this discrepancy in performance between the
18
A
AF
Trigger
cgRNA
Mean fluorescence (au)
Crosstalk
Crosstalk
XA
-
0 500 1000
B
XB
-
C
XC
-
D
XD
-
0 1-1
A
Trigger
cgRNA
B
C
D
XD
XB
XC
XA
XD
XB
XC
XA
XD
XB
XC
XA
XD
XB
XC
XA
0.7
1.0
0.7
1
0.8
1
0.5
-0.4
-1
-0.7
1
-1
1
-1
-0.5
0.5
Fold
change
1.38 ± 0.04
0.544 ± 0.016
0.254 ± 0.008
0.761 ± 0.014
Figure 2.7: Programmable conditional function of four orthogonal 15 nt insert
splinted switch cgRNAs with silencing dCas9 in E. coli. Expression of RNA trigger
X (30 nt + synthetic terminator) is designed to toggle the cgRNA from ON→OFF,
and is intended to result in an increase in fluorescence for functional cgRNAs. Left:
Raw fluorescence depicting ON→OFF conditional response to cognate trigger (fold
change = OFF/ON = [(cognate trigger)−AF]/[(no trigger)−AF]). Right: normal-
ized fluorescence depicting orthogonality between noncognate cgRNA/trigger pairs
(crosstalk = [(noncognate trigger) − (no trigger)]/[(cognate trigger) − (no trigger)]).
Induced expression (aTc) of silencing dCas9 and constitutive expression of mRFP
target gene Y. Autofluorescence (AF): cells with no mRFP. Single-cell fluorescence
intensities via flow cytometry. Bar graphs depict mean ± estimated standard error
calculated based on the mean single-cell fluorescence over 37,096–45,965 cells for
each of N = 3 replicate wells (with the exception of cgRNA D + trigger D, which
had N = 2 replicate wells; fold change and crosstalk calculated with uncertainty
propagation).
in vitro setting and E. coli notwithstanding, this result underscores the need for
systematic study of the tolerance of gRNA sequence and structure to modification
for the production of both the ON state and the OFF state, specific to regulation
via inhibition of transcriptional elongation in E. coli. A description of the study
of domain dimensioning for engineering constitutively active sequence-independent
cgRNAs in E. coli is provided in the next chapter.
19
C h a p t e r 3
STUDY OF DOMAIN DIMENSIONING FOR CONSTITUTIVELY
ACTIVE SEQUENCE-INDEPENDENT cgRNAS IN E. COLI
To elucidate the structure/function relationship of the gRNA through modification,
and to establish the design space of allosteric ON→OFF cgRNAs (i.e., constitutively
active cgRNAs with trigger X sequence-independent of output Y, Figure 3.1a), we
undertook a systematic study of unstructured sequence inserts into the standard
gRNA structure, seeking to identify inserts that satisfied two key properties:
• well-tolerated by dCas9, so that the ON state is similar to that of the standard
gRNA, and
• upon hybridization to a cognate trigger, inactivates the cgRNA to permit a clean
OFF state.
a
i) 5’ extension
ii) Handle loop
iii) Terminator loop 1
iv) Terminator loop 2
Constitutively
Active
cgRNA
X
Y
silencing dCas9
Intended (ON     OFF) logic for 
candidate cgRNA mechanisms
b
Figure 3.1: Logic and schematic for single and double sequence inserts for con-
struction of allosteric cgRNAs in E. coli. (a) Intended (ON→OFF) conditional
logic for candidate cgRNA mechanisms. (b) Schematic depicting sequence insert
locations (blue). Designed sequences of 15, 25, and 35 nt were inserted into the
standard gRNA sequence at either one or two of the four insert sites: i) 5′ exten-
sion (sequence added to the 5′ end of the gRNA; no other sequence replaced); ii)
Cas9 handle loop (designed sequence replacing the 4 nt standard gRNA handle
loop sequence [GAAA]); iii) Terminator loop 1 (designed sequence replacing the 4
nt standard gRNA sequence of the first S. pyogenes terminator loop [GAAA]); iv)
Terminator loop 2 (designed sequence replacing the 3 nt standard gRNA sequence
of the second S. pyogenes terminator loop [AGT]).
We tested candidate cgRNAs with designed unstructured sequence inserts of each of
three lengths (15, 25, and 35 nt) at each of four insert sites (5′-extension, Cas9 handle
loop, terminator loop 1, terminator loop 2; Figure 3.1b) or at pairwise combinations
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of insert sites, with and without expression of a complementary cognate trigger
(complementary to insert sequence for single inserts, or concatenated complement
of two inserts for pairwise combinations). Insert sequences were designed for each
of the candidate cgRNAs and their corresponding triggers using the reaction pathway
engineering tools within NUPACK, employing a design formulation analogous to
that of the in vitro splinted switch cgRNA (Chapter 2), but with an updated version of
NUPACK (v3.2) enabling the use of the “minus” operator to enable a more compact
specification with one Reactants tube for each of N candidate cgRNAs (rather than
two reactants tubes per system) and a single Global Crosstalk tube (rather than one
crosstalk tube per noncognate cgRNA/trigger pair, Figure 3.2). Shorter inserts at
each site were designed to be subsequences of longer inserts (e.g., 35 nt handle loop
sequence ≡ 25 nt handle loop sequence + 10 additional nucleotides, 25 nt handle
loop sequence ≡ 15 nt handle loop sequence + 10 additional nucleotides, etc.). The
set of cognate interactions excluded from the Global Crosstalk tube in this case is
the set of all cgRNA:trigger complexes with intended complementarity, including
cases where there is only partial intended complementarity (e.g., the complex of the
candidate cgRNA with a single 35 nt handle loop insert and the 25 nt handle loop
trigger is excluded from the Global Crosstalk tube).
To determine an upper bound for ON state performance of candidate cgRNAs in E.
coli expressing silencing dCas9, the low fluorescence ideal ON state was measured
using the standard gRNA with genomically incorporated sfGFP as the target Y. To
check whether the inserts in a given candidate cgRNA are tolerated by both dCas9
and downstream interaction with target, we measured fluorescence for a cgRNA-
only strain (ON state) for each of the 34 candidate cgRNAs. To check for conditional
inactivation of the cgRNA by the cognate trigger, we measure fluorescence for a
cgRNA + trigger strain (OFF state). The ideal OFF state is measured for a strain
expressing a no-target gRNA lacking the target-binding region. Autofluorescence
(AF) is measured for a strain expressing no fluorescent protein reporters. A total
of 71 strains were used to quantify performance of single and double inserts: AF,
no-target gRNA, standard gRNA, 16 single-insert cgRNA-only (no trigger), 16
single-insert cgRNA + cognate trigger, 18 double-insert cgRNA-only (no trigger),
and 18 double-insert cgRNA + cognate trigger.
The raw data are displayed for all insert combinations in Figure 3.3a-c withmoderate
induction of dCas9 (2 nM aTc). For the cgRNA without trigger, all modifications
appear well-tolerated by dCas9, with strong ON state silencing activity comparable
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Step 1n {G·X}n {G, X}n ∪ ΨL≤Lmax1n
Crosstalk ∪n=1,...,N {λreactiven } ΨL≤Lmaxglobal − ∪n=1,...,N {λ
cognate
n }
Figure 3.2: Target test tubes for sequence design of candidate single and double
sequence insert cgRNAs. Top: Example target test tube schematics. Bottom: Target
test tube details. Each target test tube contains the depicted on-target complexes
(each with unstructured insert sequence in the cgRNA and trigger monomers and
fully paired designed sequence in the cgRNA:trigger duplex, as depicted in exam-
ples; target concentration of 10 nM for each) and the off-target complexes listed in the
table (each with vanishing target concentration). The example on-target structures
depicted above correspond to the 15 nt handle loop insert candidate cgRNA. For the
single-stranded input species Gssn of double insert candidate cgRNAs, the interven-
ing standard gRNA sequence and structure were included between insert domains.
The set of cognate interactions λcognaten includes all cgRNA:trigger complexes with
intended complementarity. To simultaneously design N candidate cgRNAs, the
total number of target test tubes is |Ω| = 2N + 1. Lmax = 2 for all tubes. Design
conditions: RNA in 1 M Na+ at 37 ◦C.38
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to the standard gRNA. For each candidate cgRNA, the cognate trigger corresponds
to the expressed reverse complement of the inserted designed sequence plus a
synthetic terminator. Expression of the cognate RNA trigger is intended to toggle
the cgRNA from ON→OFF leading to an increase in fluorescence. A quantity
of interest for assessing candidate cgRNA performance is the fractional dynamic
range, the ratio of candidate cgRNA dynamic range (OFF − ON) to the ideal
dynamic range defined by the standard gRNA and no-target gRNA controls (FDR
= [OFF − ON]/[ideal OFF − ideal ON]). Tables C.1–C.3 report values for ON,
OFF, fold change (OFF/ON), dynamic range (OFF − ON), and fractional dynamic
range for each dCas9 induction condition. The candidate cgRNA with the highest
fractional dynamic range at the moderate (2 nM aTc) dCas9 induction condition was
a double modification with 35 nt inserts in the dCas9 handle loop and the terminator
loop 1 (an improved “splinted switch” cgRNA mechanism, discussed at length in
Chapter 4, with insert lengths and locations different from the in vitro splinted
switch mechanism described in Chapter 2). The candidate cgRNAs with two 25
nt or two 35 nt inserts in the 5′ extension and dCas9 handle, corresponding to the
5′ extension/handle insert splinted switch cgRNA of Chapter 2 with longer inserts,
also exhibit a large dynamic range; this suggests that the basic mechanism validated
in vitro is functional in E. coli, but requires longer trigger binding domains to toggle
the cgRNA ON→OFF, highlighting the necessity of domain dimensioning studies
specific to the intended setting (i.e., with the particular buffer/lysate/cell and protein
effector of interest) for cgRNA mechanism engineering.
Fractional dynamic range for all insert combinations with low, moderate, and high
dCas9 induction (0.2, 2, and 20 nM aTc, respectively) is provided in Figure 3.3d.
For each candidate cgRNA that produces a distinct conditional response (absolute
value fractional dynamic range > 0.01), we observe a decrease in fractional dynamic
range with increased dCas9 induction (as well as decreased absolute dynamic range,
see Tables C.1–C.3). This trend is unsurprising, as we would expect an increase
in dCas9 concentration to favor cgRNA:dCas9 complex formation (i.e., the active
complex), in both the absence and presence of trigger. The magnitude of this effect,
however, is significant (e.g., a decrease of FDR ≈0.5 to ≈0.02 in the most extreme
case), and suggests that increasing the strength of cgRNA:trigger hybridization (as
compared to the cgRNA:dCas9 interaction) may be important for the engineering of
more robust cgRNAs. The potential to improve cgRNA OFF state and conditional
response by designing stronger cgRNA:trigger interaction is also supported by the
positive correlation between insert length and fractional dynamic range, apparent
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Figure 3.3: Performance of single and double sequence inserts for construction of
allosteric cgRNAs in E. coli (cont’d). (a) Single insert conditional response (15, 25,
and 35 nt at each of four insert sites). (b) Double insert conditional response (15,
25, and 35 nt at 5′ extension plus same length of insert at each of three other insert
sites). (c) Double insert conditional response (15, 25, and 35 nt inserts for remaining
combinations of two insert sites) plus alternative single insert sequences for 15 and
25 nt handle loop and terminator loop 1. Panels a-c: Induced expression (2 nM aTc)
of silencing dCas9 and constitutive expression of sfGFP target gene Y and either:
no-target gRNA, standard gRNA, candidate cgRNA without trigger, or candidate
cgRNA + cognate trigger. Autofluorescence: cells with no sfGFP. Raw fluorescence
via flow cytometry: mean ± estimated standard error based on the mean single-cell
fluorescence over 20,000 cells for each of N = 3 replicate wells. Data for each
panel a-c collected on different days. (d) Conditional response for all single- and
double-insert candidate cgRNAs with varying induction of dCas9 (0.2, 2, and 20
nM aTc). Fractional dynamic range decreases with increasing dCas9 induction for
each candidate cgRNA. Fractional dynamic range = [OFF −ON]/[ideal OFF − ideal
ON], calculated with uncertainty propagation.
for those cgRNAs that produce a distinct conditional response. Another key insight
suggested by these data is the importance of the handle loop insert in producing
an ON→OFF conditional response in this setting. The top 10 highest fractional
dynamic ranges observed each correspond to candidate cgRNAs that contain a
handle loop insert of 25 nt or more, including the 35 nt single handle loop insert.
Using NUPACK analysis for complex free energy prediction, it is possible to predict
the change in free energy for the hybridization reaction of cgRNA and trigger (i.e.
∆∆G, where ∆∆G = ∆GcgRNA:trigger − [∆GcgRNA + ∆Gtrigger], see Table C.4). Com-
parison of the observed fractional dynamic range for each candidate cgRNA and
the predicted |∆∆G| of cgRNA:trigger duplex formation (from NUPACK analysis
with RNA in 1 M Na+ at 37 ◦C) reveals a positive correlation (Figure C.1), with
a significant increase in sensitivity to trigger (i.e., increased slope, with decreased
mean squared error of a least squares fitted line118 for each dCas9 induction condi-
tion) when limited to those candidate cgRNAs that incorporate a handle loop insert
(Figure 3.4). With increasing dCas9 induction, we observe a decrease in the slope
of a least squares fitted line (fitted using least squares regression weighted by inverse
estimate of variance of the mean118 due to varying estimates of variance over three
replicate wells for each candidate cgRNA), suggesting that high expression of dCas9
diminishes our ability to produce a stronger conditional response by increasing the
strength of cgRNA:trigger hybridization. With intermediate and high dCas9 induc-
25
tion (2 and 20 nM aTc, Figure 3.4b-c, respectively), the fractional dynamic range
of one candidate cgRNA remained notably high, namely the double modification
with 35 nt inserts in the dCas9 handle loop and the terminator loop 1; this alterna-
tive “splinted switch” cgRNA mechanism is discussed further in Chapter 4. The
relationship between fractional dynamic range, ∆∆G, and dCas9 induction points to
the potential to improve the automated design of cgRNA sequences by incorporat-
ing some proxy for the energetics of cgRNA:dCas9 complex formation. Wright et
al. reported an experimentally determined equilibrium dissociation constant (Kd)
for the gRNA/catalytically active Cas9 complex,119 but values for the catalytically
dead dCas9 have yet to be reported. Quantitation of free cgRNA, cgRNA:trigger
duplex, and cgRNA:dCas9 complex with titration of dCas9 may be possible by
a combination of electrophoretic mobility shift120 and filter binding assay,119 and
could enable the inference of the cgRNA/dCas9 binding energy. In the absence of
a physical model representing cgRNA/dCas9 interaction, cgRNA performance may
be improved by simply constraining the design to produce cgRNA/trigger pairs with
increased |∆∆G|, either by specifying minimum G-C content for a particular target
structure or by specifying a “soft constraint” target |∆∆G| for the binding domains
or cgRNA:trigger duplex. Of the candidate cgRNAs tested here, the observed high
fractional dynamic range and robustness to dCas9 induction of the double 35 nt
handle/terminator insert “splinted switch” cgRNA motivates further study of this
mechanism; a description of the design and validation of a set of orthogonal splinted
switch cgRNAs is provided in the following chapter.
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Figure 3.4: Fractional dynamic range vs predicted ∆∆G of trigger binding for
candidate cgRNAs with handle loop insert. (a) 0.2 nM aTc induction of dCas9.
(b) 2 nM aTc induction of dCas9. (c) 20 nM aTc induction of dCas9. Fractional
dynamic range is higher for cgRNA:trigger pairs with high |∆∆G|, but decreases
with increased dCas9 induction. ∆∆G values calculated using NUPACK analysis
(RNA in 1 M Na+ at 37 ◦C,38 ∆∆G = ∆GcgRNA:trigger − [∆GcgRNA + ∆Gtrigger], see
Table C.4). Fractional dynamic range: mean ± estimated standard error based on
N = 3 replicate wells with uncertainty propagation. Fitted lines calculated using
least squares regression weighted by inverse estimate of variance of the mean,118
equation for the line of best fit and the estimate of mean squared error (MSE) of the
fit are provided as inset.
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C h a p t e r 4
ENGINEERING ORTHOGONAL CONSTITUTIVELY ACTIVE
cgRNAS IN E. COLI VIA HYBRIDIZATION OF TARGET
SEQUENCE-INDEPENDENT MODIFICATIONS
4.1 Automated sequence design of orthogonal constitutively active splinted
switch cgRNAs using NUPACK
The constitutively active “splinted switch” cgRNA mechanism identified through
the domain dimensioning studies of Chapter 3 has 35 nt extended loops in both the
Cas9 handle (domain “d”, Figure 4.1b) and terminator (domain “e”), intended to
minimally interfere with downstream cgRNA-mediated dCas9 function in the ON
state (Figure 4.1b reaction arrow “i”). Hybridization of RNA trigger X to both loops
is intended to form a splint that is structurally incompatible with cgRNA-mediated
dCas9 function (Figure 4.1b reaction arrow “ii”), yielding the conditional logic: “if
not X, then not Y” (Figure 4.1a). This splinted switch mechanism exhibited the
highest fractional dynamic range of all single and double insert candidate cgRNAs
with both moderate (2 nM aTc) and high (20 nM aTc) dCas9 induction (Figure 3.3d),
and the observed performance compared to other candidate cgRNAs with similar
∆∆G for cgRNA:trigger hybridization (Figure 3.4b-c) suggests that this cgRNA
mechanism is particularly robust.
Following validation of the conditional response of a single splinted switch cgRNA
sequence in E. coli, we sought to more rigorously test the programmability of the
splinted switch mechanism. To do so, a set of four orthogonal cgRNA/trigger se-
quences was designed using the reaction pathway designer within NUPACK.35,37
Target structureswere defined using a combination of subsequenceminimum free en-
ergy (MFE) structures predicted by NUPACK, and the requirements for the intended
mechanism function (Figure 4.2a). Although the target-binding region sequence
(domain “u” in Figure 4.1b) was fully constrained for this design, the target-binding
region target structure was defined to be unstructured to penalize the inadvertent
contribution of interactions with designed sequence domains to an increased prob-
ability of target-binding region base pairing, as a highly structured target-binding
region can reduce gRNA activity.95,98,121 To minimize perturbation of the effector-
specific standard gRNA structure in the cgRNA ON state (single-stranded cgRNA),
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Figure 4.1: Constitutively active splinted switch cgRNAs (ON→OFF logic) with
silencing dCas9 in E. coli. (a) Conditional logic: if not X, then not Y. (b) Schematic
of cgRNAmechanism. ON state: the splinted switch cgRNA is constitutively active,
directing the function of protein effector dCas9 (reaction arrow “i”) to a target gene
Y in the absence of trigger; the extended loops in the Cas9 handle and terminator
region (blue) are intended to not interfere with the activity of the cgRNA:dCas9
complex. OFF state: in the presence of RNA trigger X, hybridization of the trigger
is intended to form a splint (reaction arrow “ii”) that is structurally incompatible
with cgRNAmediation of dCas9 function, thereby inactivating the cgRNA. Rational
sequence design of the 35 nt Cas9 handle loop (domain “d”) and an extended 35 nt
terminator hairpin loop (domain “e”).
the target base-pairing state of the remaining constrained sequence was designed
to be that of the MFE structure, with the exception of the exterior handle region
wobble pair (G-U), which has been shown to form experimentally via X-ray crys-
tallography.108 It should be noted that although this G-U wobble pair forms in the
gRNA:effector complex, the current implementation of the RNA secondary struc-
ture physical model37 associates a maximal penalty with an exterior G-U wobble
pair, and as such it may be advisable to define the G-U wobble pair as unstruc-
tured in future implementations for which this is consequential (e.g., for the design
of potentially unstructured target-binding regions). Similarly, target structures for
domains constrained by the synthetic terminator (BBa_B1006 trigger terminator)
and standard gRNA subsequences (inter-handle/terminator loop standard gRNA se-
quence for single-stranded input and cgRNA:trigger duplex, pre-handle loop and
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post-terminator loop standard gRNA sequence for cgRNA:trigger duplex, Figure
4.2a) were defined to be their respective MFE structures. Designed sequence was
defined to be unstructured in the ON state (single-stranded reactant state) to maxi-
mize accessibility for cgRNA/trigger hybridization. Designed sequence was defined
to be fully paired between trigger and complementary cgRNA insert sequence in
the OFF state target structure (cgRNA:trigger duplex product state) to maximize
cgRNA/trigger affinity for a given sequence, consistent with the intended mecha-
nism.
Within the ensemble defect, defect weights (see Section S1.6 in the Supplementary
Information of Wolfe et al.37) were applied to prioritize design effort for each se-
quence domain within each on-target complex as depicted in Figure 4.2b. Designed
sequence domains were assigned the highest weight across target complexes (w = 3)
to minimize interaction with constrained sequence domains, maximize accessibility
in the reactant state, and prioritize a well formed OFF state (with cgRNA:trigger
complex formation dominated by the interaction of designed complementary se-
quence domains). Constrained sequence domains within the single-stranded re-
actant cgRNA and trigger complexes were assigned a weight of w = 1, with the
exception of the Cas9 handle region, which was given a higher priority weight (w
= 1.5) due to its structural importance for interaction with Cas9.89,90 Constrained
sequence domains were given the lowest priority (w = 0) in the cgRNA:trigger
duplex (OFF state), as the base pairing states of these domains are both inflexible
(i.e., sequence is fully constrained) and inconsequential to the mechanism function.
The fully constrained inter-handle/terminator loop sequence of the single-stranded
input target structure was also assigned a weight of w = 0, as the internal structure of
this domain is inconsequential for designing against pseudoknotted crosstalk inter-
actions. The particular weight values assigned for the final design were determined
through iterative design trials and assessment of design quality. Future study of
the structure/function relationship of the guide RNA may enable improvements in
automated sequence design by providing a basis for a finer resolution (or otherwise
better informed) defect weighting scheme.
Sequence design was formulated as a multistate optimization problem using target
test tubes to represent reactant and product states of cgRNA/trigger hybridization,
as well as to model crosstalk between orthogonal cgRNAs (Figure 4.3). Target test
tubes were specified using the general formulation of Section S2.2.1 in the Sup-
plementary Information of Wolfe et al.37 Each reactants tube (Step 0) and products
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Figure 4.2: Target structure definition and nucleotide defect weights for sequence
design of splinted switch cgRNAs. (a) Splinted switch cgRNA target structures,
and constrained subsequence minimum free energy (MFE) secondary structures
used for target structure definition with associated equilibrium pair probabilities
(calculated using NUPACK, RNA in 1 M Na+ at 37 ◦C38). The target-binding
region was defined to be unstructured in all target structures; the G-U wobble pair
on the exterior of the handle hairpin was defined to be paired in the target cgRNA
structure; other constrained subsequences were defined to have their respectiveMFE
structures as target structure. Designed sequence target structure was unstructured
in the ON state and fully hybridized in the OFF state, consistent with the intended
mechanism. (b) Nucleotide defect weights for sequence design of splinted switch
cgRNAs. Nucleotides in a given sequence domain within a given complex are
assigned a defect weight w as depicted.
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tube (Step 1) contains a set of desired “on-target” complexes (each with a target
secondary structure and target concentration) corresponding to the on-pathway hy-
bridization products for a given step, and a set of undesired “off-target” complexes
(each with a target concentration of 0 nM) corresponding to on-pathway reactants
and off-pathway hybridization crosstalk for a given step. Hence, these elementary
step tubes are designed for full conversion of cognate reactants into cognate products
and against local hybridization crosstalk between these same reactants. To simulta-
neously design N orthogonal systems, elementary step tubes are specified for each
system (Figure 4.3; left). Furthermore, to design against off-pathway interactions
between systems, a single global crosstalk tube is specified (Figure 4.3; right). In
the global crosstalk tube, the on-target complexes correspond to all reactive species
generated during all elementary steps (m = 0, 1) for all systems (n = 1, . . . , N),
including single-stranded input complexes (Gssn , to enable negative design against
pseudoknotted crosstalk interactions without explicitly incorporating pseudoknotted
structures); the off-target complexes correspond to noncognate interactions between
these reactive species. Crucially, the global crosstalk tube ensemble omits the cog-
nate products that the reactive species are intended to form (i.e., they appear as
neither on-targets nor off-targets). Hence, all reactive species in the global crosstalk
tube are forced to either perform no reaction (remaining as desired on-targets) or
undergo a crosstalk reaction (forming undesired off-targets), providing the basis for
minimization of global crosstalk during sequence optimization. Note that for the
design of a library of N orthogonal cgRNA/trigger pairs, all N cgRNAs have the
same on-target structure, and all N triggers have the same on-target structure; within
a library, the only difference between cgRNA/trigger pairs designed sequence.
Sequence designs were performed for a library of four orthogonal cgRNA/trigger
pairs for several independent design trials. For a given design trial, the sequences
were optimized by mutating the sequence set to reduce the multi-tube ensemble
defect37 subject to the diverse sequence constraints depicted in Figure 4.3 (top).
An additional constraint preventing four consecutive repeats of a single base (viz.
[AAAA], [CCCC], [GGGG], [UUUU]) was applied to the designed sequence domains
for each cgRNA/trigger pair. A final sequence set was selected from the inde-
pendent design trials for experimental testing based on inspection of the predicted
structural defects (fraction of nucleotides in the incorrect base-pairing state within
the ensemble of an on-target complex, see Figure 4.4 example) and concentration
defects (fraction of nucleotides in the incorrect base-pairing state because there is
a deficiency in the concentration of an on-target complex) for species in the con-
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Figure 4.3: Target test tubes for sequence design of orthogonal splinted switch
cgRNAs. Top: Target test tube schematics. Bottom: Target test tube details. Each
target test tube contains the depicted on-target complexes (each with the depicted
target structure and a target concentration of 10 nM) and the off-target complexes
listed in the table (each with vanishing target concentration). To simultaneously
design N orthogonal systems, the total number of target test tubes is |Ω| = 2N + 1.
Lmax = 2 for all tubes. Design conditions: RNA in 1 M Na+ at 37 ◦C.38
text of the target test tubes,36,37 and the predicted computational orthogonality of
the set of cgRNA/trigger sequences via NUPACK analysis of each cgRNA in the
presence of each noncognate trigger (Figure 4.5). For the design trial selected,
the predicted structural defects depicted in Figure 4.4 (cgRNA A, trigger XA) are
typical—on-target complexes are predicted to form with quantitative yield at the tar-
get concentrations, but with some unintended base-pairing (nucleotides not shaded
dark red). These structural defects within the ensemble of on-target complexes
reflect the real-world challenges of designing a cgRNA that satisfies biological se-
quence constraints, changes conformation in response to a cognate RNA trigger,
and operates orthogonally to a library of other cgRNAs. In particular, generating
a library of four orthogonal trigger sequences with 70 contiguous unstructured nu-
cleotides presents an obvious design challenge. In spite of these structural defects,
each cgRNA (A, B, C, and D) is predicted to interact appreciably only with its
cognate RNA trigger (and with quantitative yield; Figure 4.5).
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Figure 4.4: Analysis of design quality by equilibrium pair probability (cont’d).34,35
(a) Equilibrium pair probabilities for splinted switch cgRNA A. (b) Equilibrium
pair probabilities for splinted switch trigger XA. Nucleotides shaded and scaled to
indicate the probability of adopting the depicted base-pairing state at equilibrium.
Pairing states in the target structure are indicated with black circles. For this design,
all on-target complexes are predicted to form with quantitative yield at the 10 nM
target concentration, but some nucleotides have unwanted base-pairing interactions
(circled nucleotides not shaded dark red, uncircled nucleotides with significant pair
probability), notably the low probability of cgRNA handle stem formation (panel
a) and the high probability of undesired base pairing between domains “e*” and
“d*” of the trigger (panel b). Equilibrium pair probabilities for splinted switch
cgRNA:trigger complex A are provided in Figure D.1.
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Figure 4.5: Computational orthogonality study for splinted switch design. Predicted
equilibrium concentration of each cgRNA:trigger complex for each pairwise com-
bination of cgRNA and trigger from the library of four systems (one cgRNA species
and one RNA trigger species per tube). RNA in 1 M Na+ at 37◦C.38
4.2 Performance of orthogonal constitutively active splinted switch cgRNAs
in E. coli
To screen for performance of the cgRNA ON state, E. coli expressing silencing
dCas9, a fluorescent protein reporter (sfGFP) as the target gene Y, and constitutively
expressed cgRNA were characterized using time course microplate fluorescence
(Figure 4.6). In comparison to the ideal ON state of the standard gRNA, we
observe a near-ideal ON state for thee of the four cgRNAs characterized (A, B, and
35
C), with distinctly poorer performance for cgRNA D. The nature of this distinctly
reduced activity was not identified, but several possible explanations exist, including
sequence-dependent expression issues and significant tertiary structure (not captured
by computational analysis) interfering with the function of the cgRNA. On this
basis, the three cgRNA/trigger pairs A, B, and C were selected for full experimental
characterization.
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Figure 4.6: Characterization of ON state of four orthogonal splinted switch cgRNAs
in E. coli. Fluorescence of cgRNAs A–C with no trigger (ON state) overlap with
the standard gRNA (ideal ON state), while cgRNA D yields significantly higher
fluorescence. Time course microplate fluorescence data normalized by A600. Mean
± estimated standard error over N = 3 replicate wells.
cgRNA-only (ON) and cgRNA+trigger (OFF) strains were characterized by flow
cytometry in E. coli expressing silencing dCas9 and a fluorescent protein reporter
(sfGFP) as the target gene Y. The splinted switch exhibits a conditional ON→OFF
response to expression of RNA trigger X (Figure 4.7a), with a strong ON state
comparable to the ideal ON state of a standard gRNA, and an OFF state with
significant potential for improvement relative to the ideal OFF state of a no-target
gRNA lacking the target binding region (consistent with results from the domain
dimensioning studies, Figure 3.3c). Examining the library of three orthogonal
splinted switch cgRNA/trigger pairs (Figure 4.7b; left), we observe a median ≈15-
fold ON→OFF conditional response with the expression of cognate trigger. With
a pairwise expression of each cgRNA (A, B, and C) with each trigger (XA, XB,
and XC) (Figure 4.7b; right), we observe high selectivity for cognate trigger for
the conditional response of each cgRNA, with median crosstalk of ≈2% between
noncognate cgRNA/trigger combinations. The strong conditional response and
demonstrated programmability of this mechanism suggest that the splinted switch
36
mechanism, and the cgRNA paradigm more broadly, offers a promising platform
for conditional programmable regulation in living cells.
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Figure 4.7: Programmable conditional function of three orthogonal splinted switch
cgRNAs (ON→OFF logic) with silencing dCas9 in E. coli. (a) Expression of RNA
trigger X toggles the cgRNA fromON→OFF, leading to an increase in fluorescence.
Single-cell fluorescence intensities via flow cytometry. Induced expression (aTc)
of silencing dCas9 and constitutive expression of sfGFP target gene Y and either:
standard gRNA (ideal ON state), cgRNA (ON state), cgRNA + RNA trigger X (OFF
state), or no-target gRNA that lacks target-binding region (ideal OFF state). Aut-
ofluorescence (AF): cells with no sfGFP. (b) Programmable conditional regulation
using three orthogonal cgRNAs (A, B, and C). Left: Raw fluorescence depicting
ON→OFF conditional response to cognate trigger (fold change = OFF/ON = [(cog-
nate trigger)−AF]/[(no trigger)−AF]). Right: normalized fluorescence depicting
orthogonality between noncognate cgRNA/trigger pairs (crosstalk = [(noncognate
trigger) − (no trigger)]/[(cognate trigger) − (no trigger)]). Bar graphs depict mean ±
estimated standard error calculated based on the mean single-cell fluorescence over
20,000 cells for each of N = 3 replicate wells (fold change and crosstalk calculated
with uncertainty propagation).
4.3 Increasing fractional dynamic range of splinted switch cgRNAs
The conditional and orthogonal performance of the library of splinted switch cgR-
NAs in living cells highlights their promise and potential usefulness for some regu-
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latory applications. Comparison of the cgRNA OFF state with the ideal OFF state
of the no-target gRNA control (Figure 4.7a), however, points to an obvious potential
for improvement, namely improving the performance of the cgRNA OFF state and
hence the fractional dynamic range of the splinted switch mechanism. One potential
means to improve the OFF state of this mechanism, discussed in Chapter 3, is to
specify target structures and/or to design sequences with an increased |∆∆G| of
cgRNA:trigger hybridization, by extending the designed sequence domains and/or
constraining the designed sequence to have a higher G-C content. A potential
means to improve the performance of the cgRNA OFF state and the corresponding
fractional dynamic range with no change to the cgRNA itself (i.e., using the same
cgRNA/trigger sequences) is dCas9 loading competition. gRNA loading competi-
tion has been reported elsewhere as a means to characterize the affinity of various
gRNAs for Cas9,121,122 with lower affinity gRNAs identified by their reduced activ-
ity in the presence of a competitor gRNA; by the same token, if the modifications
made to the standard gRNA structure to produce the splinted switch cgRNA reduce
its affinity for dCas9, expression of a no-target gRNA competitor will displace some
fraction of the cgRNA that would otherwise be bound by dCas9 (with adequately
low dCas9 expression), thereby potentially improving its OFF state. dCas9 loading
competition was examined for splinted switch cgRNA C with triggers XA (stringent
ON state), XB (stringent ON state), and XC (cognate trigger, OFF state) with lacI-
regulated expression of a no-target gRNA competitor (Figure 4.8). With increasing
competitor induction (i.e., increasing [IPTG]), we observed an increase in fluores-
cence for both cognate trigger OFF state and noncognate trigger ON state strains
(Figure 4.8a-c). Crucially, the competition had a differential effect on OFF and
stringent ON state fluorescence, resulting in an increase in the fractional dynamic
range with increased competitor expression (Figure 4.8d), although at the expense
of the ON state performance. Examining the standard gRNA (ideal ON) and no-
target gRNA (ideal OFF) controls reveals that the observed increase in fractional
dynamic range is in part due to a reduction of the ideal dynamic range; however, the
majority of the increase is in fact due to an increase in the absolute dynamic range
with increased expression of the no-target gRNA competitor. This approach may be
applicable to other cgRNAmechanisms as well (likely in amechanism-specificman-
ner; provided the cgRNA modifications influence effector affinity, a higher affinity
standard gRNAmay serve as a competitor for dCas9 loading), and suggests a means
for improving the dynamic range of cgRNA response for applications in which the
benefit of an increase in absolute dynamic range outweighs the potential worsening
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of the ON state.
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Figure 4.8: Characterization of splinted switch performance with lacI-regulated
expression of no-target gRNA competitor. Panels (a-d): Time course microplate
fluorescence data normalized by A600. Simultaneous induction of dCas9 (0.2 nM
aTc) and no-target gRNA competitor with (a) 0 µM (b) 12.5 µM (c) 250 µM or (d)
5000 µM IPTG at t = 0, with constitutive expression of other gRNA/cgRNA and
trigger species. Increasing IPTG induction of no-target gRNA competitor leads to
an increase in fluorescence for both cgRNA ON state (noncognate trigger) and OFF
state (cognate trigger). (e) Fractional dynamic range of cgRNA C + noncognate
trigger (XA, XB) at t = 12 h for different no-target competitor gRNA induction
conditions (0-5000 µM IPTG). Increasing induction of no-target gRNA competitor
leads to an increase in fractional dynamic range. Fractional dynamic range = [OFF
− ON]/[ideal OFF − ideal ON].
4.4 Characterization of cgRNA temporal response with induction of cognate
trigger
The study of candidate cgRNA function described for the splinted switchmechanism
above and the domain dimensioning studies of Chapter 3 have focused primarily
on end point assays to characterize the conditional response of candidate cgRNAs
39
in the presence or absence of a cognate trigger in separate E. coli strains. To
gain insight into the temporal response of cgRNAs to trigger expression, and to
validate the trigger dependence of the observed conditional ON→OFF response
in a single E. coli strain, we characterized the splinted switch cgRNA sequence
identified in Chapter 3 with constitutive cgRNA expression (BBa_J23114 promoter,
Table A.8) and induced expression of the cognate RNA trigger (BBa_R0011 lacI-
regulated promoter, Table A.8). In E. coli expressing lacI, silencing dCas9, and a
fluorescent protein reporter (sfGFP) as the target gene Y, the splinted switch exhibits
a conditional ON→OFF response with fully induced expression of RNA trigger X
(5 mM IPTG, Figure 4.9a). At low trigger induction ([IPTG] = 0), we observe
comparable fluorescence for a strain bearing a constitutive cgRNA + lacI-regulated
trigger expression plasmid and for a strain with constitutive cgRNA expression
only (Figure 4.9b). With increasing trigger induction, we observe no significant
change in fluorescence for the cgRNA-only strain (ON state), but monotonically
increasing fluorescence for the cgRNA + lacI-regulated trigger strain, confirming
that the magnitude of conditional response is dependent upon trigger expression,
and the cgRNA behaves as designed. Time course microplate fluorescence studies
(Figure 4.9c) of the sameE. coli strains with trigger expression induced several hours
(4-7 h) post dCas9 induction yields the expected increase in observed normalized
fluorescence, with normalized fluorescence of the uninduced cgRNA + pLac-trigger
remaining comparable to that of the cgRNA-only strain for the duration of the
experiment. Subtraction of the mean normalized fluorescence of uninduced cgRNA
+ pLac-trigger from each induction time course (Figure 4.9d) reveals time-resolved
dependence of the conditional response on induction of cognate trigger, with a
substantial increase in∆(Fluorescence/A600) observed 1–2 h after trigger induction.
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Figure 4.9: Characterization of splinted switch response to lacI-regulated trigger
expression in E. coli. (a) Expression of RNA trigger X induced by IPTG toggles the
cgRNA from ON→OFF, leading to an increase in fluorescence. Induced expression
(aTc) of silencing dCas9 and constitutive expression of sfGFP target gene Y and
either: standard gRNA (ideal ON state), cgRNA (ON state), cgRNA + RNA trigger
X (OFF state; trigger expression is IPTG-induced), or no-target gRNA that lacks
target-binding region (ideal OFF state). Autofluorescence (AF): cells with no sfGFP.
Trigger expression was induced simultaneously with dCas9 expression (5 mM IPTG
in each well). (b) ON→OFF conditional response increases with trigger expression
level (induced by IPTG). (c) Time course microplate fluorescence data normalized
by A600. Identical color traces represent N = 3 replicate wells. Induction of trigger
(5 mM IPTG, time of induction indicated by arrows) at 4, 5, 6, and 7 h post dCas9
induction (2 nM aTc at t = 0). (d) Difference in normalized fluorescence between:
1) cgRNA + trigger induced by IPTG (5 mM IPTG, time of induction indicated by
arrows) and 2) uninduced cgRNA + trigger (-IPTG). Induction of trigger expression
leads to an increase in fluorescence 1–2 h after addition of IPTG. Flow cytometry
(a-b): mean ± estimated standard error calculated based on the mean single-cell
fluorescence over 20,000 cells for each of N = 3 replicate wells. Time course data
(c-d): mean ± estimated standard error (with uncertainty propagation) over N = 3
replicate wells.
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C h a p t e r 5
ENGINEERING ORTHOGONAL CONSTITUTIVELY INACTIVE
cgRNAS IN E. COLI VIA SEQUESTRATION OF THE TARGET
BINDING REGION
To enable both gene induction and gene silencing in the same setting (i.e., with
the same Cas9 variant in the same organism) and to provide cgRNAs for the spa-
tiotemporal control of gene knockdown which minimally perturb the natural system
(i.e., with low global activity), it is desirable to engineer a constitutively inactive
cgRNA that is conditionally activated in the presence of a trigger X (OFF→ON
logic, Figure 5.1a). To implement the OFF→ON conditional logic, we designed
a constitutively inactive “toehold switch” cgRNA mechanism (Figure 5.1b). The
target-binding region of the cgRNA (domain “u”) is initially sequestered by a 5′
extension to inhibit recognition of target gene Y, providing the OFF state in the
absence of a cognate trigger. Hybridization of trigger X to this extension through
toehold-mediated branch migration is intended to desequester the target-binding
region (reaction arrow “i”), yielding a cgRNA:trigger duplex (ON state) capable of
directing dCas9 function to target gene Y (reaction arrow “ii”).
A set of four orthogonal cgRNA/trigger sequences was designed using the reaction
pathway designer within NUPACK.35,37 Analogous to the design specification used
for the in vitro splinted switch cgRNAmechanism (Chapter 2), sequence design was
formulated as a multistate optimization problem using target test tubes to represent
reactant and product states of cgRNA/trigger hybridization, as well as to model
crosstalk between orthogonal cgRNAs (Figure 5.2a). As with the design of in vitro
splinted switch cgRNA, this design used a previous version of NUPACK that did
not yet support exclusion of a set of complexes from a target test tube, and hence
a set of crosstalk tubes was specified (Figure 2.3; right) with each noncognate pair
defined explicitly as its own tube to design against off-pathway interactions between
systems. Within the ensemble defect, defect weights were applied to prioritize
design effort (Figure 5.2b).
To screen for performance of the cgRNA ON state of this constitutively inactive
cgRNA, E. coli expressing silencing dCas9, a fluorescent protein reporter (mRFP)
as the target gene Y, and constitutively expressed cgRNA + cognate trigger (ON
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Figure 5.1: Constitutively inactive toehold switch cgRNAs (ON→OFF logic) with
silencing dCas9 in E. coli. (a) Conditional logic: if X, then not Y. (b) Schematic
of cgRNA mechanism. OFF state: the toehold switch cgRNA is constitutively
inactive; the target-binding region (domain “u”; orange) is initially sequestered by
a 5′ extension to inhibit recognition of target gene Y. ON state: in the presence of
RNA trigger X, hybridization of the trigger to this 5′ extension (reaction arrow “i”)
via the toehold region (blue) is intended to desequester the target-binding region and
enable cgRNA direction of dCas9 function to target gene Y (reaction arrow “ii”).
state) were characterized using time course microplate fluorescence (Figure 5.3). In
comparison to the ideal ON state of the standard gRNA, we see room for improve-
ment for each of the four cgRNA/trigger pairs characterized, with distinctly poorer
performance of cgRNA D + trigger XD. On this basis, the three cgRNA/trigger
pairs A, B, and C were selected for full experimental characterization.
Conditional response of the toehold switch mechanism was characterized by flow
cytometry in E. coli expressing silencing dCas9 and a fluorescent protein reporter
(mRFP) as the target gene Y (Figure 5.4a). The toehold switch cgRNA exhibits a
conditional OFF→ON response to the expression of RNA trigger X, with OFF state
imperfect relative to the ideal OFF state (no-target gRNA control) and the ON state
imperfect relative to the ideal ON state (standard gRNA control). For a library of
three orthogonal toehold switch cgRNA/trigger pairs, we observe a median ≈3-fold
OFF→ON conditional response to the expression of the cognate trigger and median
crosstalk of ≈20% between noncognate cgRNA/trigger combinations. Recently, Siu
and Chen demonstrated a median ≈6.6-fold OFF→ON conditional response using
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Figure 5.2: Target test tubes for sequence design of orthogonal toehold switch cgR-
NAs. (a) Top: Target test tube schematics. Bottom: Target test tube details. Each
target test tube contains the depicted on-target complexes (each with the depicted
target structure and target concentration) and the off-target complexes listed in the
table (each with vanishing target concentration). The on-target structures depicted
above are used in the mechanism schematic of Figure 5.1. To simultaneously de-
sign N orthogonal systems, the total number of target test tubes is |Ω| = N2 + 2N .
Lmax = 2 for all tubes. Design conditions: RNA in 1 M Na+ at 37 ◦C.38 (b) Nu-
cleotide defect weights for sequence design of toehold switch cgRNAs. Nucleotides
in a given sequence domain within a given complex are assigned a defect weight w
as depicted.
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Figure 5.3: Characterization of ON state of four orthogonal toehold switch cgRNAs
inE. coli. Fluorescence traces of cgRNAsA–Cwith cognate trigger are overlapping,
while cgRNA D with cognate trigger produces significantly higher fluorescence
(further from ideal ON standard gRNA). Time course microplate fluorescence data
normalized by A600. Mean ± estimated standard error over N = 3 replicate wells.
toehold switch cgRNAs with subtly different structural details in the sequestration
of the target-binding region.98
In an effort to improve performance of the toehold switch mechanism, we investi-
gated the effect of the cognate trigger domain length on the activity of the cgRNA
ON state. The effect of trigger domain length on ON state activity was characterized
by time course microplate fluorescence for strains constitutively expressing toehold
switch cgRNA A, and cognate trigger XA with truncations of the strand displace-
ment domain “u” (0-20 nt stem trigger, Figure 5.5a) and truncations or extension
of the toehold domain “d*” (0-20 nt toehold trigger, Figure 5.5b; 20 nt extended
toehold domain strain also included a 5 nt complementary extension for cgRNA
toehold domain “d”; see Figure 5.1b for domain labeled mechanism schematic).
As expected, we observed a significant increase in fluorescence with expression
of the cognate trigger lacking the strand displacement domain (i.e., hybridization
toehold domain only is insufficient to produce the observed OFF→ON conditional
response; cgRNA A + 0 nt stem trigger, Figure 5.5a). Somewhat surprisingly, a
strand displacement domain of only 5 nt (cgRNA A + 5 nt stem trigger) resulted
in a significant decrease in fluorescence, and an OFF→ON conditional response
comparable to that of the full-length strand displacement domain (cgRNA A + 20
nt stem trigger). This suggests that the sequestration of the target-binding region
by the 20 nt reverse complementary sequence of the 5′ extension is marginal, and
hence that the cgRNA OFF state could be improved through extension of the target-
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Figure 5.4: Programmable conditional function of three orthogonal toehold switch
cgRNAs (OFF→ON logic) with silencing dCas9 in E. coli. (a) Expression of RNA
trigger X toggles the cgRNA from OFF→ON, leading to a decrease in fluorescence.
Single-cell fluorescence intensities via flow cytometry. Induced expression (aTc) of
silencing dCas9 and constitutive expression of mRFP target gene Y and either: no-
target gRNA that lacks target-binding region (ideal OFF state), cgRNA (OFF state),
cgRNA + RNA trigger X (ON state), or standard gRNA (ideal ON state). Aut-
ofluorescence (AF): cells with no mRFP. (b) Programmable conditional regulation
using three orthogonal cgRNAs (A, B, and C). Left: Raw fluorescence depicting
OFF→ON conditional response to cognate trigger (fold change = OFF/ON = [(no
trigger)−AF]/[(cognate trigger)−AF]). Right: Normalized fluorescence depicting
orthogonality between noncognate cgRNA/trigger pairs (crosstalk = [(noncognate
trigger) − (no trigger)]/[(cognate trigger) − (no trigger)]). Bar graphs depict mean ±
estimated standard error calculated based on the mean single-cell fluorescence over
20,000 cells for each of N = 3 replicate wells (fold change and crosstalk calculated
with uncertainty propagation).
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binding region (orange domain “u” in Figure 5.1b). Truncation of trigger strand
displacement domains to 5 nt could potentially yield a significant improvement to
the orthogonality of the library of cgRNAs, as the strand displacement domain “u” is
shared between all triggers and may be a major contributor to crosstalk. Truncation
of the toehold domain by only three nucleotides (cgRNA A + 12 nt toehold trigger,
Figure 5.5b) results in a significant loss of cgRNA function, while a 5 nt extension
of both trigger and cgRNA toehold (cgRNA A-20 + 20 nt toehold trigger) performs
no better than the 15 nt toehold.
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Figure 5.5: Characterization of toehold switch cgRNA with varied trigger domain
dimensions. (a) Performance of cgRNA ON state with 0-20 nt strand displacement
domain (truncation of domain “u”). Triggers with 0-20 nt strand displacement
domain were expressed constitutively with the the previously characterized cognate
cgRNA (with 15 nt toheold domain “d”, 20 nt sequestration domain “u*”). A
5 nt strand displacement domain was sufficient for achieving the observed ON
state. (b) Performance of cgRNA ON state with 0-20 nt trigger toehold region
(truncation of trigger domain “d*”, or extension of trigger domain “d*” and cgRNA
domain “d”). Triggers with 0-15 nt toehold domains were expressed constitutively
with the previously characterized cognate cgRNA A (with 15 nt cgRNA domain
“d”). Trigger with an extended 20 nt toehold domain was expressed constitutively
with an extended-toehold cognate cgRNA (20 nt cgRNA domain “d”). Trigger
toeholds of length 0-12 nt did not toggle the cgRNA fromOFF→ON. TheOFF→ON
conditional response with a 20 nt cgRNA/trigger toehold is comparable to the
previously characterized 15 nt toehold. Time course microplate fluorescence data
normalized by A600. Mean ± estimated standard error over N = 3 replicate wells.
Unlike the splinted switch mechanism for ON→OFF logic, toehold switch cgR-
NAs for OFF→ON logic are not allosteric, as the cgRNA initially down-regulates
cgRNA:dCas9 function by sequestering the target-binding region with a portion of
the trigger-binding region (orange domain “u*” in Figure 5.1b), resulting in only
partial sequence-independence between trigger X and target gene Y (as “u” is a
47
subsequence of both X and Y). This partial sequence dependence is not necessarily
limiting for synthetic biology applications where the trigger can be rationally de-
signed and expressed exogenously, but does pose a limitation in situations where
X and Y are both endogenous sequences. Another potential limitation for the de-
tection of endogenous sequences is the likely continued association of trigger with
cgRNA in complex with dCas9 (i.e., the cgRNA is bound by trigger in its active
conformation), as the presence of a long (e.g., hundreds or thousands of nucleotides
for mRNA) trigger may inhibit the downstream function of the Cas protein effector.
This is of particular concern in eukaryotes, in which the active transport of mRNAs
out of the nucleus will potentially sequester active cgRNA:trigger:effector complex
from nuclear dsDNA targets. The relatively poor conditional response as compared
to existing ON→OFF mechanisms (including the splinted switch mechanism of
Chapter 4), the partial sequence dependence of trigger X and target Y, and poten-
tial issues for use of the toehold switch cgRNA with mRNA triggers motivate the
development of an improved constitutively inactive cgRNA with a fundamentally
different mechanism. However, the library of toehold cgRNAs developed exhibited
the intended OFF→ON conditional function with selectivity for cognate trigger,
and, with potential improvements to orthogonality, may prove useful as regulators
for synthetic biology.
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C h a p t e r 6
CONCLUSIONS AND FUTURE DIRECTIONS
The present work represents only a first step toward our long-term goal of engineer-
ing programmable conditional regulators that function robustly in living organisms.
Here, I describe progress on multiple fronts: 1) In vitro, we demonstrate a candi-
date molecular mechanism for conditional regulation with conditional guide RNAs
(cgRNAs) in a reconstituted setting, with direct evidence of the interactions of the
species involved (cgRNA, trigger, target, and Cas9 effector protein), and the pro-
grammability of this cgRNA mechanism based on nucleic acid hybridization; 2) In
E. coli expressing candidate cgRNAs with an array of sequence inserts in the pres-
ence and absence of an insert-complementary trigger, we demonstrate that gRNA
activity tolerates significant modification to its structure, and provide a basis for en-
gineering allosteric (i.e., sequence-independent) cgRNAs for conditional regulation
in living organisms; 3) In E. coli expressing cgRNA regulators and RNA triggers,
we demonstrate mechanisms for both logical directions of conditional regulation:
ON→OFF logic with constitutively active cgRNAs that are conditionally inactivated
by a cognate RNA trigger, and OFF→ON logic with constitutively inactive cgR-
NAs that are conditionally activated by a cognate RNA trigger; 4) To leverage the
programmability of these dynamic regulators, we establish a computational frame-
work for automated sequence design of libraries of orthogonal cgRNA/trigger pairs
using the reaction pathway engineering tools within NUPACK; 5) These contribu-
tions, in sum, demonstrate the applicability of dynamic RNA nanotechnology for
programmable conditional regulation in living cells. In order to develop cgRNAs
into a versatile platform for biological research, a number of major improvements
are needed. The work presented here points to several prospective paths forward,
discussed in the following sections, followed by a discussion of the near- and longer-
term applications that programmable conditional regulation with cgRNAs might
enable.
6.1 Developing cgRNA mechanisms with improved dynamic range
The single and double insert studies of candidate cgRNAs detailed in Chapter 3
yielded a maximum observed conditional response of ≈41-fold and a maximum
fractional dynamic range of ≈0.2 at moderate induction of dCas9, compared to the
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>200-fold conditional response and unity fractional dynamic range of the standard
gRNA (ideal ON) and no-target gRNA (ideal OFF) controls (Table C.2), with per-
formance seemingly limited by an OFF state with significantly higher (undesirable)
activity than that of the control. For a library of orthogonal splinted switch cgRNAs
(Chapter 4), we observed a further reduction in both conditional response and dy-
namic range, as could be expected for sequence design subject to more significant
constraint. Although the mechanisms described here are of potential use as con-
ditional regulators for synthetic biology, for the more highly constrained design of
conditional regulators as a tool for biological study with endogenous trigger it is de-
sirable to exploit the full regulatory dynamic range of standard gRNAs and achieve
>100-fold conditional responses. One potential means to improve the dynamic
range of conditional regulation with cgRNAs is to improve the observed OFF state
via competition of a no-target gRNA with higher putative affinity for dCas9, as was
described in Section 4.2. An improved OFF state could also be achieved by incor-
porating modifications that destabilize the gRNA structure but do not significantly
effect ON state activity,89 plausibly “lowering the bar” for conditional response via
hybridization of trigger. For ON→OFF mechanisms in which OFF state is lim-
ited by the undesirable activity of a cgRNA:trigger:effector:dsDNA quadruplex (the
extent of which has yet to be characterized), the use of Cas9 engineered to have
reduced affinity for dsDNA binding123 may also improve the dynamic range.
The development of novel cgRNA mechanisms and/or refinement of the sequence
design process is also merited in the pursuit of cgRNA mechanisms with improved
performance. The increased fractional dynamic range observed for both a) an
increase in trigger binding domain length, and b) a decrease in dCas9 expression
(Chapter 3) suggests that engineering cgRNAs with increased |∆∆G| of trigger
hybridization may improve performance. With the present design approach, we
are limited by our ability to design long, unstructured sequence for orthogonal
cgRNA/trigger pairs (e.g., a target structure of 70 consecutive unpaired nucleotides
for the splinted switch trigger). The current design implementation uses “long”
domains (i.e., designed domains of adequate length) and “unstructured” domains of
designed sequence in combination as a proxy to guarantee adequate |∆∆G| of trigger
hybridization. Defining sequence similarity constraints to increase G-C content of
the designed sequence is possible with the current version of NUPACK, and is an
easily implementable approach to increasing |∆∆G| of trigger hybridization without
a computationally expensive increase in domain length. Intentional introduction of
structure into the designed sequence domains (i.e., specified complementaritywithin
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the target structure of the currently unstructured inserts) with a concurrent increase
in domain length could further increase trigger affinity while preserving our ability
to design orthogonal regulators; this approach would also be potentially compatible
with G-C content similarity constraints to ensure adequate |∆∆G| for a given target
structure. The extent towhich such structured inserts are tolerated by the cgRNAON
state, however, has yet to be characterized. Recent developments in the NUPACK
design algorithm enable another possible path to increasing cgRNA/trigger affinity,
namely the use of “soft constraints”—secondary design objectives that are not strictly
satisfied throughout the design iteration—which allow for the explicit specification
of a target duplex free energy, and, combined with a decreased weight for insert
domain target structure, could be used for the automated design of sequences with
(potentially) structured inserts and high |∆∆G| of trigger hybridization. Novel
mechanism designs in which the cgRNA is composed of two or more strands, with
nicks in the solvent-exposed loops (as is the case for the wild-type CRISPR/Cas9
guide RNA56,60), would allow for sequestration of part of the cgRNA OFF state,
yielding a bimolecular leakage reaction (i.e., association of the two halves of the
cgRNA) and hence reduced dCas9 affinity for the cgRNA in its OFF state. These
“split cgRNAs” would have the added benefit of mitigating topological limitations to
trigger hybridization,124 which would be particularly relevant for long (e.g., mRNA)
trigger species.
In pursuing improved cgRNA performance, further understanding of the struc-
ture/function relationships between cgRNAs, triggers, and Cas effectors is needed
to ascertain how to robustly achieve both a strong ON state and a clean OFF state
depending on the presence/absence of the cognate trigger, and to identify the un-
derlying causes of current performance limitations. Studying the effect of sequence
and structural modifications at a higher resolution (i.e., beyond the four insert sites
detailed here) may inform the design of novel cgRNA mechanisms. For our current
cgRNAs, we have yet to fully characterize the mechanism by which the cgRNA
OFF state is achieved; the observed conditional response could potentially result
from inhibition of cgRNA:dCas9 complex formation, inhibition of dsDNA target
binding by the cgRNA:dCas9 complex, decreased silencing efficacy with a fully
formed cgRNA:dCas9:target complex, or a combination of the above. As such, the
key determinants of the non-ideal OFF-state performance are unknown. In vitro
study of the interactions of cgRNAs, triggers, Cas effectors, and dsDNA targets
(similar to those described in Chapter 2, but using dCas9 as the protein effector)
may shed light on the mechanism of action and hence direct efforts to address non-
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ideal performance. Lastly, toward the use of cgRNAs for conditional regulation
in eukaryotes, a systematic study of candidate cgRNA modifications analogous to
that of Chapter 3 is merited. We have successfully demonstrated the conditional re-
sponse of a library of constitutively active cgRNAs in cultured mammalian cells,125
but mammalian-specific optimization of cgRNA mechanisms will be needed for
improved performance.
6.2 Detection of endogenous mRNA inputs with cgRNAs
To enable tissue-selective regulation in living organisms, it is critical that cgRNAs
are able to efficiently detect a trigger that is a subsequence of a longer endogenous
RNA (e.g., a subsequence of an mRNA). Detection of a subsequence of a full-
length mRNA poses significant additional challenges relative to detection of a short
RNA trigger,45,98 increasing the degree of difficulty in achieving a conditional
response that exploits the full dynamic range. The strategies for improving cgRNA
performance described above will be of key importance for achieving this goal, but
challenges specific to endogenous mRNA targets exist as well. Significant constraint
of the sequence of trigger-binding domains (constrained to be complementary to a
window of the endogenous trigger sequence) poses a challenge to the design of
cgRNA sequence; relaxing overall constraint on design by allowing the target-
binding region to be selected from a library of PAM-adjacent sequences within
the target gene may be beneficial. Mechanisms with partial sequence dependence
(such as the toehold switch mechanism) will not be compatible with the use of
and endogenous trigger, and as such the development of sequence-independent (i.e.,
allosteric) mechanisms is essential. cgRNA mechanisms with secondary structure
intentionally incorporated into insert domains (discussed in Section 6.1) also pose
a challenge to the selection of an endogenous trigger, as windows of endogenous
sequence need to be compatible with the target structure; as such, for structured
inserts, it may be necessary to engineermechanismswith insert domains that are only
partially complementary to the constrained trigger. The accessibility of the cgRNA-
hybridizing subsequence of an endogenous trigger may also prove to be an issue due
to secondary or tertiary structure of the longer RNA sequence, and/or competition
with endogenous binding proteins; screening of candidate trigger subsequences for
high accessibility by in vitro45 or in vivo126,127 methods may be required to enable
the design of functional cgRNAs with endogenous trigger.
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6.3 Mechanism engineering for versatile constitutively inactive (OFF→ON)
cgRNAs
As discussed in Chapter 5, the toehold switch mechanisms studied here and else-
where98 have partial sequence dependence between target and trigger. For future
applications, it is important that cgRNA regulators be allosteric, so that the sequence
of target gene Y places no restriction on the sequence of RNA trigger X, enabling
independent control over the regulatory scope (using X) and the regulatory target
(using Y). The use of mRNA or other endogenous species as trigger may also be
incompatible with the toehold switch cgRNA mechanism and other mechanisms in
which the active state of the cgRNA is the cgRNA:trigger complex, particularly in
eukaryotic cells, in which mRNA and other endogenous targets are actively exported
from the nucleus and hence actively sequestered from nuclear downstream targets.
A constitutively inactive mechanism (OFF→ON) is, however, particularly valuable
for spatiotemporal control of gene knockdown with minimal perturbation to the
natural system, as downstream function is only mediated by cgRNA in cells with
the tissue marker of interest. The incompatibility with future applications of interest
and the relatively poor performance of the toehold switch mechanism motivates the
development of a fundamentally different constitutively inactive mechanism. The
goals of sequence-independence and mobility (i.e., dissociation from trigger) of
the ON state of an OFF→ON cgRNA could be achieved by the logical inversion
of an ON→OFF cgRNA. Expression of a duplex as a single transcript linked by
a self-cleaving ribozyme128 would insure a 1:1 stoichiometric ratio of strands for
multi-stranded cgRNAs (note that this self-cleaving approach to generating multi-
stranded cgRNAs may present a issue if an uncleaved transcript is active, resulting
in a poor OFF state). Finally, development of RNA-targeting Cas13 cgRNAs could
circumvent issues of cgRNA:mRNA association, as endogenous trigger X and RNA
target Y could both be localized to the cytoplasm; however, the tolerance of the
Cas13 gRNA to modification has yet to be adequately established.
6.4 Future applications for cgRNAs
The ability to rationally design cgRNAs suggests a conceptual framework for en-
abling biologists to exert spatiotemporal control over regulatory perturbations in
living organisms using CRISPR/Cas technology. The target of regulation, target Y,
is programmed via the cgRNA target-binding sequence, which can be reprogrammed
as desired. A trigger X can be selected to restrict downstream regulatory functions
to only those cells that express trigger X, thereby targeting a specific cell type,
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tissue, organ, or temporal expression profile. For allosteric (sequence-independent)
cgRNA mechanisms, trigger X and target Y can be selected independently, provid-
ing a versatile tool for probing genetic circuitry and studying the role of genes that
lead to unwanted developmental perturbations (including lethality) when regulated
globally with existing programmable regulators. If engineered to be appropriately
robust, this same cgRNA logic would have attractive therapeutic potential. Restrict-
ing gene editing to a tissue or cell type of interest could provide a basis for gene
therapy limited to cells in which a disease is manifest. Similarly, with trigger X as
a programmable disease marker and target Y as an essential target, regulation with
cgRNAs could enable targeted treatment via conditional cell death.
The potential to design large libraries of interoperable cgRNA/trigger components
makes cgRNA regulation an ideal platform for scalable synthetic biology. With
mechanisms for both ON→OFF and OFF→ON logical directions, and the ability
to select other cgRNA or trigger species as the target of transcriptional regulation,
cgRNA regulation may be implemented to construct large, integrated, and complex
circuits.
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A p p e n d i x A
MATERIALS AND METHODS
A.1 Rational design of libraries of orthogonal cgRNAs using NUPACK
For each mechanism, orthogonal cgRNA/trigger pairs were designed using the reac-
tion pathway engineering tools within NUPACK (nupack.org; see the NUPACK
3.2 User Guide).35,37 Target test tubes were specified using the general formulation
of Section S2.2.1 in the Supplementary Information of Wolfe et al.37 using the def-
initions provided below for the splinted switch mechanism of Chapter 4. Sequence
designs were performed for libraries of four orthogonal cgRNA/trigger pairs. For
a given design trial, the sequences were optimized by mutating the sequence set to
reduce the multi-tube ensemble defect37 subject to the diverse sequence constraints
for each mechanism. Within the ensemble defect, defect weights (see Section S1.6
in the Supplementary Information ofWolfe et al.37) were applied to prioritize design
effort. Designs were performed using RNA parameters for 1 M Na+ at 37 ◦C.38
After performing several independent design trials for a given mechanism, a final
sequence set was selected for experimental testing based on inspection of the pre-
dicted structural defects (fraction of nucleotides in the incorrect base-pairing state
within the ensemble of an on-target complex) and concentration defects (fraction of
nucleotides in the incorrect base-pairing state because there is a deficiency in the
concentration of an on-target complex) for species in the context of the target test
tubes,36,37 as well as for each cgRNA in the presence of each non-cognate trigger.
After preliminary experimental studies, cgRNA/trigger pairs were selected for full
experimental characterization.
Example design specification: splinted switch cgRNA in E. coli.
To design N orthogonal systems, the total number of target test tubes is |Ω| =∑
n=1,...,N {Step 0, Step 1}n + Crosstalk = 2N + 1; the target test tubes in the multi-
tube ensemble, Ω, are indexed by h = 1, . . . , |Ω|. Lmax = 2 for all tubes (i.e.,
each target test tube contains all off-target complexes of up to two strands). Final
sequence designs for orthogonal cgRNAs/trigger pairs A, B, C, and D are shown in
Table A.5.
Reactants for system n
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• cgRNAs: Gn
• Triggers: Xn
Elementary step tubes for system n
• Step 0n tube: Ψproducts0n ≡ {G, X}n; Ψreactants0n ≡ ∅; Ψexclude0n ≡ {G·X}n
• Step 1n tube: Ψproducts1n ≡ {G·X}n; Ψreactants1n ≡ {G, X}n; Ψexclude1n ≡ ∅
Global crosstalk tube
• Crosstalk tube: Ψreactiveglobal ≡ ∪n=1,...,N {λreactiven }; Ψcrosstalkglobal ≡ ΨL≤Lmaxglobal −∪n=1,...,N {λcognaten }
The reactive species and cognate products for system n are:
• λsimplen ≡ {G, X}n
• λss-outn ≡ Xn
• λss-inn ≡ Gssn , the 35nt single stranded handle and terminator loop insert domains,
with intervening gRNA sequence
• λreactiven ≡ {G, X, Gss}n
• λcognaten ≡ {G·X, Gss·X}n
Sequence constraints
• Assignment constraints: portions of the cgRNA are constrained to match stan-
dard gRNA sequences for use with dCas9 (shaded gray in Figure 4.2, Figure 4.3,
and Table A.5), and the synthetic terminator for the trigger is fully constrained
(shaded tan in Figure 4.2, Figure 4.3, and Table A.5).
• Watson–Crick constraints: cgRNA sequence domains “d” and “e” are con-
strained to be complementary to the trigger sequence domains “d*” and “e*”
(shaded blue in Figure 4.2, Figure 4.3, and Table A.5).
• Assignment constraint: cgRNA domain “u” is constrained to be complementary
to a subsequence of the target gene sfGFP (full template sequence in Section A.6,
constrained sequence shaded orange in Figure 4.2, Figure 4.3, and Table A.5).
• Pattern prevention constraints: the following patterns are prevented for cgRNA
sequence domains “d” and “e”: AAAA, CCCC, GGGG, UUUU.
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A.2 In vitro assay of gRNA/cgRNA activity with catalytically active Cas9
Sequences for parts used in in vitro studies are provided in Section A.4.
A double stranded DNA standard gRNA template lacking the target-binding region
(NT_g) was ordered as a gene fragment from IDT. Extended T7 promoter sequence
(T7_E), target-binding region, and modifications to the standard gRNA sequence
were added via PCR to generate dsDNA template for in vitro transcription. Follow-
ing PCR product clean up (with QIAquick PCR Purification Kit, QIAGEN #28104),
gRNAs and cgRNAs were in vitro transcribed using the T7-Scribe kit (Cellscript
#C-AS3107) as per manufacturer instructions, and IVT products were purified via
denaturing gel electrophoresis (10% polyacrylamide w/urea; eluted overnight at 4
◦C in 1x TAE +Mg2+). Trigger strands were ordered as RNA from IDT and purified
via denaturing gel electrophoresis. dsDNA target templates were ordered as gene
fragments from IDT, and amplified via PCR with subsequent PCR product clean
up (QIAquick PCR Purification Kit). For the cleavage assay, the RNA species for
each reaction (2 µL gRNA or cgRNA at 150 nM, and 2 µL trigger at 0.3 or 1.5 µM
if applicable) were added to 0.8 µL 10x NEBuffer 3.1 (NEB #B7203S) and total
volume normalized to 6 µL with water, then snap cooled by heating to 65 ◦C for
3 min and transferring to ice for 5 min (unless otherwise noted; see Figure 2.6). 2
µL purified recombinant S. pyogenes Cas9 (NEB #M0386S) diluted 6.67-fold in 1x
NEBuffer 3.1 was added to each reaction tube and incubated at room temperature
for 10 min. The reaction was started at t = 0 by adding 2 µL dsDNA target at 15
nM (10 µL final reaction volume), and incubated at 37 ◦C for 1 h. The reaction was
halted by denaturing Cas9with a 10min incubation at 70 ◦C. Reaction products were
characterized by nondenaturing gel electrophoresis (4–20% Mini-PROTEAN TBE
Gel, Bio-Rad #4565016) with nucleic acid gel stain as per manufacturer instructions
(SYBR gold stain, Thermo Fisher #S11494).
A.3 Methods for bacterial studies in E. coli
Plasmid construction and molecular cloning for bacterial cgRNA studies
Sequences for parts used in bacterial studies are provided in Section A.4.
Control gRNA and cgRNA constructs were generated by inverse PCR, inserting
sequence modifications into the previously described pgRNA-bacteria vector68 (Ad-
dgene plasmid #44251; gift from S. Qi). All PCR steps for the generation of ex-
perimental constructs were performed using Q5 Hot Start High-Fidelity polymerase
(NEB #M0494) according to manufacturer instructions using primers designed
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using standard molecular cloning techniques and synthesized by Integrated DNA
Technologies. Introduced sequences were verified by Sanger sequencing for single
colony picks via colony PCR using GoTaq Green polymerase (Promega #M7122).
For the single and double insert studies (Chapter 3) and splinted switch cgRNAs
(Chapter 4), trigger-expressing constructs were generated by first cloning synthetic
promoter, trigger template, and synthetic terminator (BBa_B1006) into a trigger-
only cassette via inverse PCR, followed by insertion of trigger cassette into the
cgRNA vector using BioBrick assembly to yield cgRNA+trigger expressing con-
structs.69,129 For the 5′ extension/handle loop splinted switch cgRNAs (Chapter 2)
and toehold switch cgRNAs (Chapter 5), trigger-expressing constructs were gener-
ated by first cloning synthetic promoter, trigger template, and synthetic terminator
(BBa_B0050) into a trigger-only cassette via inverse PCR, followed by insertion
of trigger cassette into the cgRNA vector using DNA assembly according to man-
ufacturer instructions (NEBuilder HiFi DNA Assembly, NEB #E2621) to yield
cgRNA+trigger expressing constructs.
A lacI+dCas9 expression construct was generated by inserting a lacI template se-
quence with J23108 constitutive promoter130 into the previously described pdCas9-
bateria vector68 (Addgene plasmid #44249; gift from S. Qi) between the dCas9 gene
and the p15A origin with a synthetic terminator (BBa_B0010) added upstream of
lacI as a transcriptional terminator for dCas9, using DNA assembly according to
manufacturer instructions (NEBuilder HiFi DNA Assembly, NEB #E2621).
Bacterial culture and time course microplate fluorescence silencing assay for
cgRNA studies
A previously described E. coli MG1655 strain with constitutively expressed mRFP
and sfGFP inserted into the nfsA locus68 (Ec001; gift from S. Qi) was used for all
fluorescence assays. For experiments with constitutive expression of trigger, the pre-
viously described pdCas9-bacteria vector68 (Addgene plasmid #44251) was used for
tetR-regulated dCas9 expression. For experiments with lacI-regulated expression of
trigger, the lacI+dCas9 vector was used for tetR-regulated dCas9 expression and con-
stitutive expression of lacI. Chemically competent chloramphenicol-resistant cells
carrying either the dCas9 or lacI+dCas9 construct were transformed with gRNA,
cgRNA, or cgRNA+trigger expression vectors and cultivated in EZ-RDM (Teknova
#M2105) containing 100 µg/mL carbenicillin and 34 µg/mL chloramphenicol (EZ-
RDM+Carb+Cam).
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Sequence-verified strains were grown overnight in EZ-RDM+Carb+Cam, then
seeded at 100× dilution in 100 µL fresh medium and grown at 37 ◦C with shaking
in the Neo2 microplate reader (Biotek) to monitor absorbance at 600 nm. When
cells had reached mid-log phase (≈4 h), cells were again diluted ≈100-fold in fresh
medium with cell density normalized by A600 and, if applicable, dCas9 expression
and trigger expression were induced with aTc and IPTG, respectively, in N = 3
replicate wells at 400 µL final volume in a 96-well high-volume glass bottom plate
(Matriplate, Brooks #MGB096-1-2-LG-L). A final working concentration of 2 nM
aTc was used for 35 nt insert splinted switch cgRNA experiments (Chapter 4) unless
otherwise noted, with IPTG concentration as indicated for induction experiments.
A final working concentration of 200 nM aTc was used for the 5′ extension/handle
loop splinted switch (Chapter 2) and toehold switch (Chapter 5) cgRNA experi-
ments. Induced cells were grown at 37 ◦C with continuous linear shaking for the
duration of the experiment, with A600 and fluorescence monitoring (sfGFP: 479 ±
20 nm excitation, 520 ± 20 nm emission; mRFP: 579 ± 10 nm excitation, 616 ± 20
nm emission).
Flow cytometry for bacterial cgRNA studies
Cell strains were cultured and induced as described above, and induced cells were
grown at 37 ◦Cwith continuous shaking for 12 h. Protein fluorescencewasmeasured
using the MACSQuant VYB flow cytometer (Miltenyi Biotec) using FSC/SSC to
gate for 20,000 live cells per wellat a flow rate of 25 µL/min. sfGFP fluorescence
was measured using the B1 channel (488 nm laser, 525/50 nm filter) and mRFP
fluorescence was measured using the Y2 channel (561 nm laser, 615/20 nm filter).
Quantitative fluorescence analysis for E. coli
Measuring signal in E. coli
For a bacterial strain containing a fluorescent reporter protein, the total fluorescence
(SIG+AF) in the relevant fluorescent channel (sfGFP for the 35 nt splinted switch
cgRNA and insert studies, mRFP for the toehold switch and 15 nt splinted switch
cgRNA) is a combination of signal (SIG) from the reporter and autofluorescence
(AF) inherent to the cells. Autofluorescence is characterized for a given fluorescent
channel in strainMG1655 containing no fluorescent reporters. For cell j of replicate
well i of a given bacterial strain, we denote the autofluorescence:
XAFi, j ,
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the signal:
XSIGi, j ,
and the total fluorescence (SIG + AF):
XSIG+AFi, j .
For replicate well i of a given strain, we measure the mean fluorescence (X¯SIG+AFi
for a strain containing the reporter, X¯AFi for strain MG1655 lacking reporters) over
N = 20, 000 cells. Performance across N = 3 replicate wells is characterized by the
sample means (X¯SIG+AF and X¯AF) and estimated standard errors (sX¯SIG+AF and sX¯AF).
Let (n, p) denote a strain containing cgRNA n and trigger p. The mean signal is
estimated as
X¯(n, p)SIG = X¯(n, p)SIG+AF − X¯AF
with the standard error estimated via uncertainty propagation as
sX¯(n,p)SIG ≤
√
(sX¯(n,p)SIG+AF)2 + (sX¯AF)2.
The upper bound on estimated standard error holds under the assumption that the
correlation between SIG and AF is non-negative.
Fold change for constitutively active cgRNAs (ON→OFF logic) with silencing
dCas9 in E. coli
For a constitutively active cgRNA with silencing dCas9, the ON state for cgRNA
n corresponds to low fluorescence using no trigger (p = 0) and the OFF state
corresponds to high fluorescence using cognate trigger (p = n). The fold change is
estimated as
X¯(n)OFF:ON = X¯(n, n)SIG/X¯(n, 0)SIG
with standard error estimated via uncertainty propagation as
sX¯(n)OFF:ON ≤ X¯(n)OFF:ON
√( sX¯(n,n)SIG
X¯(n, n)SIG
)2
+
( sX¯(n,0)SIG
X¯(n, 0)SIG
)2
.
The upper bound on estimated standard error holds under the assumption that the
correlation between SIG in the two strains is non-negative.
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Dynamic range for constitutively active cgRNAs (ON→OFF logic) with
silencing dCas9 in E. coli
For a constitutively active cgRNA with silencing dCas9, the ON state for cgRNA
n corresponds to low fluorescence using no trigger (p = 0) and the OFF state
corresponds to high fluorescence using cognate trigger (p = n). The dynamic range
is estimated as
X¯(n)DR = X¯(n, n)SIG+AF − X¯(n, 0)SIG+AF
with standard error estimated via uncertainty propagation as
sX¯(n)DR ≤
√
(sX¯(n,n)SIG+AF)2 + (sX¯(n,0)SIG+AF)2.
The upper bound on estimated standard error holds under the assumption that the
correlation between SIG+AF in the two strains is non-negative.
Fold change for constitutively inactive cgRNAs (OFF→ON logic) with
silencing dCas9 in E. coli
For a constitutively inactive cgRNA with silencing dCas9, the OFF state for cgRNA
n corresponds to high fluorescence using no trigger (p = 0) and the ON state
corresponds to low fluorescence using cognate trigger (p = n). The fold change is
estimated as
X¯(n)OFF:ON = X¯(n, 0)SIG/X¯(n, n)SIG
with standard error estimated via uncertainty propagation as
sX¯(n)OFF:ON ≤ X¯(n)OFF:ON
√( sX¯(n,0)SIG
X¯(n, 0)SIG
)2
+
( sX¯(n,n)SIG
X¯(n, n)SIG
)2
.
The upper bound on estimated standard error holds under the assumption that the
correlation between SIG in the two strains is non-negative.
Dynamic range for constitutively inactive cgRNAs (OFF→ON logic) with
silencing dCas9 in E. coli
For a constitutively inactive cgRNA with silencing dCas9, the OFF state for cgRNA
n corresponds to high fluorescence using no trigger (p = 0) and the ON state
corresponds to low fluorescence using cognate trigger (p = n). The dynamic range
is estimated as
X¯(n)DR = X¯(n, 0)SIG+AF − X¯(n, n)SIG+AF
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with standard error estimated via uncertainty propagation as
sX¯(n)DR ≤
√
(sX¯(n,0)SIG+AF)2 + (sX¯(n,n)SIG+AF)2.
The upper bound on estimated standard error holds under the assumption that the
correlation between SIG+AF in the two strains is non-negative.
Fractional dynamic range for cgRNAs with silencing dCas9 in E. coli
For a cgRNA with silencing dCas9, the ideal OFF state corresponds to high fluo-
rescence with a no-target gRNA lacking the target-binding region and the ideal ON
state corresponds to low fluorescence with a standard gRNA with a target-binding
region for the target Y. The ideal dynamic range is estimated as
X¯DRideal = X¯
SIG+AF
no-target − X¯SIG+AFstandard
with standard error estimated via uncertainty propagation as
sX¯DRideal ≤
√
(sX¯SIG+AFno-target )2 + (sX¯SIG+AFstandard )2.
The upper bound on estimated standard error holds under the assumption that the
correlation between SIG+AF in the two strains is non-negative. The fractional
dynamic range is estimated as
X¯(n)FDR = X¯(n)DR/X¯DRideal
with standard error estimated via uncertainty propagation as
sX¯(n)FDR ≤ X¯(n)FDR
√( sX¯(n)DR
X¯(n)DR
)2
+
( sX¯DRideal
X¯DRideal
)2
.
The upper bound on estimated standard error holds under the assumption that the
correlation between the ideal dynamic range and the cgRNA dynamic range is
non-negative.
Crosstalk for orthogonal cgRNAs in E. coli
Crosstalk (CT) is estimated for cgRNA n with trigger p as
X¯(n, p)CT = [X¯(n, p)SIG+AF − X¯(n, 0)SIG+AF]/[X¯(n, n)SIG+AF − X¯(n, 0)SIG+AF]
with the standard error estimated via uncertainty propagation as
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sX¯(n,p)CT ≤X¯(n, p)CT
((√(sX¯(n,p)SIG+AF)2 + (sX¯(n,0)SIG+AF)2
X¯(n, p)SIG+AF − X¯(n, 0)SIG+AF
)2
+
(√(sX¯(n,n)SIG+AF)2 + (sX¯(n,0)SIG+AF)2
X¯(n, n)SIG+AF − X¯(n, 0)SIG+AF
)2) 12
.
The upper bound on estimated standard error holds under the assumption that the
correlation between strains is non-negative. Note that crosstalk values can be
positive or negative. The bar graphs for orthogonality studies are annotated with
X¯(n, p)CT except that in instances where | X¯(n, p)CT | < sX¯(n,p)CT , we instead report
X¯(n, p)CT + sX¯(n,p)CT as an estimated upper bound.
The bar graphs for the bacterial studies for orthogonality studies plot normalized
fluorescence. For replicate well i of cgRNA n and trigger p, the normalized mean
fluorescence over 20,000 cells is
X¯(n, p)Normi = [X¯(n, p)SIG+AFi − X¯(n, 0)SIG+AF]/[X¯(n, n)SIG+AF − X¯(n, 0)SIG+AF].
The bar graphs display the mean normalized fluorescence over N = 3 replicate
wells (X¯(n, p)Norm) ± the standard error of the mean (sX¯(n,p)Norm) calculated treating
the normalizing values X¯(n, 0)SIG+AF and X¯(n, n)SIG+AF as exact (i.e., sX¯Normn,p is
calculated without error propagation) so as to display the uncertainty corresponding
to the particular trigger p with cgRNA n. By contrast, sX¯(n,p)CT is calculated with
error propagation so as to characterize the uncertainty arising from cognate trigger
(p = n), noncognate trigger (p , n), and no trigger (p = 0) with cgRNA n.
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A.4 Part sequences for cgRNA, trigger, and control gRNA
Splinted switch mechanism in vitro
Name Sequence Legend
IVSS_5pA 5′-GGGATAATAAAAGAAAACTTTCAGTTTAGCGGTCTGTTTTAGA
GCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGA
AAAAGTGGCACCGAGTCGGTGCTTTTTTT-3′
5′ A
IVSS_5pB 5′-GGGCATAAGTGTAGAAACTTTCAGTTTAGCGGTCTGTTTTAGA
GCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGA
AAAAGTGGCACCGAGTCGGTGCTTTTTTT-3′
5′ B
IVSS_5pC 5′-GGGAAACAGCAACATAACTTTCAGTTTAGCGGTCTGTTTTAGA
GCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGA
AAAAGTGGCACCGAGTCGGTGCTTTTTTT-3′
5′ C
IVSS_5pD 5′-GGGAGAAATTATGATAACTTTCAGTTTAGCGGTCTGTTTTAGA
GCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGA
AAAAGTGGCACCGAGTCGGTGCTTTTTTT-3′
5′ D
IVSS_hlA 5′-AACTTTCAGTTTAGCGGTCTGTTTTAGAGCTACGAACGAAATA
AAAGTAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAA
GTGGCACCGAGTCGGTGCTTTTTTT-3′
Handle A
IVSS_hlB 5′-AACTTTCAGTTTAGCGGTCTGTTTTAGAGCTAATAAGAATAAT
AAAGTAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAA
GTGGCACCGAGTCGGTGCTTTTTTT-3′
Handle B
IVSS_hlC 5′-AACTTTCAGTTTAGCGGTCTGTTTTAGAGCTATAAAGAGTGAA
TAGGTAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAA
GTGGCACCGAGTCGGTGCTTTTTTT-3′
Handle C
IVSS_hlD 5′-AACTTTCAGTTTAGCGGTCTGTTTTAGAGCTATGGAGAAGTAA
GAAGTAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAA
GTGGCACCGAGTCGGTGCTTTTTTT-3′
Handle D
IVSS_cgA 5′-GGGATAATAAAAGAAAACTTTCAGTTTAGCGGTCTGTTTTAGA
GCTACGAACGAAATAAAAGTAGCAAGTTAAAATAAGGCTAGTCCGT
TATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTTT-3′
A/A
cgRNA A
cgRNA
IVSS_cgB 5′-GGGCATAAGTGTAGAAACTTTCAGTTTAGCGGTCTGTTTTAGA
GCTAATAAGAATAATAAAGTAGCAAGTTAAAATAAGGCTAGTCCGT
TATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTTT-3′
B/B
cgRNA B
IVSS_cgC 5′-GGGAAACAGCAACATAACTTTCAGTTTAGCGGTCTGTTTTAGA
GCTATAAAGAGTGAATAGGTAGCAAGTTAAAATAAGGCTAGTCCGT
TATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTTT-3′
C/C
cgRNA C
IVSS_cgD 5′-GGGAGAAATTATGATAACTTTCAGTTTAGCGGTCTGTTTTAGA
GCTATGGAGAAGTAAGAAGTAGCAAGTTAAAATAAGGCTAGTCCGT
TATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTTT-3′
D/D
cgRNA D
IVSS_tA 5′-CTTTTATTTCGTTCGTTCTTTTATTATCCC-3′ trigger XA
trigger
IVSS_tB 5′-CTTTATTATTCTTATTCTACACTTATGCCC-3′ trigger XB
IVSS_tC 5′-CCTATTCACTCTTTAATGTTGCTGTTTCCC-3′ trigger XC
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Splinted switch mechanism in vitro
Name Sequence Legend
IVSS_tD 5′-CTTCTTACTTCTCCAATCATAATTTCTCCC-3′ trigger XD
Table A.2: Splinted switch sequences for in vitro studies (Chapter 2). Nucleotides
shaded orange are constrained by the target gene. Nucleotides shaded gray are con-
strained by Cas9. Nucleotides shaded blue are designed as described in Chapter 2.
Insert studies in E. coli
Part name Candidate cgRNA/trigger sequence Legend
i-15_cg 5′-TATCATCCATCAACCCATCTAATTCAACAAGAAT
TGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCT
AGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGG
TGCTTTTTTT-3′
5′ extension: 15
i-25_cg 5′-ACTATAGACTTATCATCCATCAACCCATCTAATTC
AACAAGAATTGTTTTAGAGCTAGAAATAGCAAGTTAA
AATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCA
CCGAGTCGGTGCTTTTTTT-3′
5′ extension: 25
i-35_cg 5′-GCTACTCATTACTATAGACTTATCATCCATCAAC
CCATCTAATTCAACAAGAATTGTTTTAGAGCTAGAAA
TAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTG
AAAAAGTGGCACCGAGTCGGTGCTTTTTTT-3′
5′ extension: 35
ii-15a_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGCT
ATTCGAGAAAGTTAGCAAGTTAAAATAAGGCTAGTCC
GTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTT
TTTTT-3′
Handle loop: 15a
ii-15b_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAATC
CCGTGTTCCGTGTAGCAAGTTAAAATAAGGCTAGTCC
GTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTT
TTTTT-3′
Handle loop: 15b
ii-25a_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGCT
ATTCGAGAAAGTTTCAGATCCCTAGCAAGTTAAAATA
AGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGA
GTCGGTGCTTTTTTT-3′
Handle loop: 25a
ii-25b_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAAAA
GTTTCAGATCCCGTGTTCCGTGTAGCAAGTTAAAATA
AGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGA
GTCGGTGCTTTTTTT-3′
Handle loop: 25b
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Insert studies in E. coli
Part name Candidate cgRNA/trigger sequence Legend
ii-35_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGCT
ATTCGAGAAAGTTTCAGATCCCGTGTTCCGTGTAGCA
AGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAA
GTGGCACCGAGTCGGTGCTTTTTTT-3′
Handle loop: 35
iii-15a_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGA
AATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACT
TAAACCTTACCACAATAAGTGGCACCGAGTCGGTGCT
TTTTTT-3′
Terminator loop
1: 15a
iii-15b_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGA
AATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACT
TCATTCACATAAGCACAAGTGGCACCGAGTCGGTGCT
TTTTTT-3′
Terminator loop
1: 15b
iii-25a_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGA
AATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACT
TAAACCTTACCACAATTTCACCATTCAAGTGGCACCG
AGTCGGTGCTTTTTTT-3′
Terminator loop
1: 25a
iii-25b_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGA
AATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACT
TACAATTTCACCATTCACATAAGCACAAGTGGCACCG
AGTCGGTGCTTTTTTT-3′
Terminator loop
1: 25b
iii-35_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGA
AATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACT
TAAACCTTACCACAATTTCACCATTCACATAAGCACA
AGTGGCACCGAGTCGGTGCTTTTTTT-3′
Terminator loop
1: 35
iv-15_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGAA
ATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTT
GAAAAAGTGGCACCGCAAGAACGTAACAATCGGTGCT
TTTTTT-3′
Terminator loop
2: 15
iv-25_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGAA
ATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTT
GAAAAAGTGGCACCGCAAGAACGTAACAATGAGAACA
GAACGGTGCTTTTTTT-3′
Terminator loop
2: 25
iv-35_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGAA
ATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTT
GAAAAAGTGGCACCGCAAGAACGTAACAATGAGAACA
GAAGATAGAAATACGGTGCTTTTTTT-3′
Terminator loop
2: 35
i-15_ii-15a_cg 5′-TATCATCCATCAACCCATCTAATTCAACAAGAAT
TGTTTTAGAGCTAGCTATTCGAGAAAGTTAGCAAGTT
AAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGG
CACCGAGTCGGTGCTTTTTTT-3′
5′ extension: 15 /
Handle loop: 15a
75
Insert studies in E. coli
Part name Candidate cgRNA/trigger sequence Legend
i-25_ii-25a_cg 5′-ACTATAGACTTATCATCCATCAACCCATCTAATTC
AACAAGAATTGTTTTAGAGCTAGCTATTCGAGAAAGT
TTCAGATCCCTAGCAAGTTAAAATAAGGCTAGTCCGT
TATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTT
TTT-3′
5′ extension: 25 /
Handle loop: 25a
i-35_ii-35_cg 5′-GCTACTCATTACTATAGACTTATCATCCATCAAC
CCATCTAATTCAACAAGAATTGTTTTAGAGCTAGCTA
TTCGAGAAAGTTTCAGATCCCGTGTTCCGTGTAGCAA
GTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAG
TGGCACCGAGTCGGTGCTTTTTTT-3′
5′ extension 35 /
Handle loop: 35
i-15_iii-15a_cg 5′-TATCATCCATCAACCCATCTAATTCAACAAGAAT
TGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCT
AGTCCGTTATCAACTTAAACCTTACCACAATAAGTGG
CACCGAGTCGGTGCTTTTTTT-3′
5′ extension: 15 /
Term loop 1: 15a
i-25_iii-25a_cg 5′-ACTATAGACTTATCATCCATCAACCCATCTAATTC
AACAAGAATTGTTTTAGAGCTAGAAATAGCAAGTTAA
AATAAGGCTAGTCCGTTATCAACTTAAACCTTACCAC
AATTTCACCATTCAAGTGGCACCGAGTCGGTGCTTTT
TTT-3′
5′ extension: 25 /
Term loop 1: 25a
i-35_iii-35_cg 5′-GCTACTCATTACTATAGACTTATCATCCATCAAC
CCATCTAATTCAACAAGAATTGTTTTAGAGCTAGAAA
TAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTA
AACCTTACCACAATTTCACCATTCACATAAGCACAAG
TGGCACCGAGTCGGTGCTTTTTTT-3′
5′ extension: 35 /
Term loop 1: 35
i-15_iv-15_cg 5′-TATCATCCATCAACCCATCTAATTCAACAAGAAT
TGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCT
AGTCCGTTATCAACTTGAAAAAGTGGCACCGCAAGAA
CGTAACAATCGGTGCTTTTTTT-3′
5′ extension: 15 /
Term loop 2: 15
i-25_iv-25_cg 5′-ACTATAGACTTATCATCCATCAACCCATCTAATTC
AACAAGAATTGTTTTAGAGCTAGAAATAGCAAGTTAA
AATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCA
CCGCAAGAACGTAACAATGAGAACAGAACGGTGCTTT
TTTT-3′
5′ extension: 25 /
Term loop 2: 25
i-35_iv-35_cg 5′-GCTACTCATTACTATAGACTTATCATCCATCAAC
CCATCTAATTCAACAAGAATTGTTTTAGAGCTAGAAA
TAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTG
AAAAAGTGGCACCGCAAGAACGTAACAATGAGAACAG
AAGATAGAAATACGGTGCTTTTTTT-3′
5′ extension: 35 /
Term loop 2: 35
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Insert studies in E. coli
Part name Candidate cgRNA/trigger sequence Legend
ii-15b_iii-15a_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAATC
CCGTGTTCCGTGTAGCAAGTTAAAATAAGGCTAGTCC
GTTATCAACTTAAACCTTACCACAATAAGTGGCACCG
AGTCGGTGCTTTTTTT-3′
Handle loop: 15b
/ Term loop 1:
15a
ii-25b_iii-25a_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAAA
AGTTTCAGATCCCGTGTTCCGTGTAGCAAGTTAAAA
TAAGGCTAGTCCGTTATCAACTTAAACCTTACCACAA
TTTCACCATTCAAGTGGCACCGAGTCGGTGCTTTTTT
T-3′
Handle loop: 25b
/ Term loop 1:
25a
ii-35_iii-35_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGCT
ATTCGAGAAAGTTTCAGATCCCGTGTTCCGTGTAGCA
AGTTAAAATAAGGCTAGTCCGTTATCAACTTAAACCT
TACCACAATTTCACCATTCACATAAGCACAAGTGGCA
CCGAGTCGGTGCTTTTTTT-3′
Handle loop: 35 /
Term loop 1: 35
ii-15b_iv-15_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAATC
CCGTGTTCCGTGTAGCAAGTTAAAATAAGGCTAGTCC
GTTATCAACTTGAAAAAGTGGCACCGCAAGAACGTAA
CAATCGGTGCTTTTTTT-3′
Handle loop: 15b
/ Term loop 2: 15
ii-25b_iv-25_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAAAA
GTTTCAGATCCCGTGTTCCGTGTAGCAAGTTAAAATA
AGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGC
AAGAACGTAACAATGAGAACAGAACGGTGCTTTTTT
T-3′
Handle loop: 25b
/ Term loop 2: 25
ii-35_iv-35_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGCT
ATTCGAGAAAGTTTCAGATCCCGTGTTCCGTGTAGCA
AGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAA
GTGGCACCGCAAGAACGTAACAATGAGAACAGAAGAT
AGAAATACGGTGCTTTTTTT-3′
Handle loop: 35 /
Term loop 2: 35
iii-15b_iv-15_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGA
AATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACT
TCATTCACATAAGCACAAGTGGCACCGCAAGAACGTA
ACAATCGGTGCTTTTTTT-3′
Term loop 1: 15b
/ Term loop 2: 15
iii-25b_iv-25_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGA
AATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAAC
TTACAATTTCACCATTCACATAAGCACAAGTGGCACC
GCAAGAACGTAACAATGAGAACAGAACGGTGCTTTTT
TT-3′
Term loop 1: 25b
/ Term loop 2: 25
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Insert studies in E. coli
Part name Candidate cgRNA/trigger sequence Legend
iii-35_iv-35_cg 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGA
AATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACT
TAAACCTTACCACAATTTCACCATTCACATAAGCACA
AGTGGCACCGCAAGAACGTAACAATGAGAACAGAAGA
TAGAAATACGGTGCTTTTTTT-3′
Term loop 1: 35 /
Term loop 2: 35
i-15_t 5′-GGTTGATGGATGATA-3′ 5′ extension: 15
+Trigger
i-25_t 5′-GGTTGATGGATGATAAGTCTATAGT-3′ 5′ extension: 25
+Trigger
i-35_t 5′-GGTTGATGGATGATAAGTCTATAGTAATGAGTAG
C-3′
5′ extension: 35
+Trigger
ii-15a_t 5′-ACTTTCTCGAATAGC-3′ Handle loop: 15a
+Trigger
ii-15b_t 5′-CACGGAACACGGGAT-3′ Handle loop: 15b
+Trigger
ii-25a_t 5′-GGGATCTGAAACTTTCTCGAATAGC-3′ Handle loop: 25a
+Trigger
ii-25b_t 5′-CACGGAACACGGGATCTGAAACTTT-3′ Handle loop: 25b
+Trigger
ii-35_t 5′-CACGGAACACGGGATCTGAAACTTTCTCGAATAG
C-3′
Handle loop: 35
+Trigger
iii-15a_t 5′-ATTGTGGTAAGGTTT-3′ Terminator loop
1: 15a +Trigger
iii-15b_t 5′-GTGCTTATGTGAATG-3′ Terminator loop
1: 15b +Trigger
iii-25a_t 5′-GAATGGTGAAATTGTGGTAAGGTTT-3′ Terminator loop
1: 25a +Trigger
iii-25b_t 5′-GTGCTTATGTGAATGGTGAAATTGT-3′ Terminator loop
1: 25b +Trigger
iii-35_t 5′-GTGCTTATGTGAATGGTGAAATTGTGGTAAGGTT
T-3′
Terminator loop
1: 35 +Trigger
iv-15_t 5′-ATTGTTACGTTCTTG-3′ Terminator loop
2: 15 +Trigger
iv-25_t 5′-TTCTGTTCTCATTGTTACGTTCTTG-3′ Terminator loop
2: 25 +Trigger
iv-35_t 5′-TATTTCTATCTTCTGTTCTCATTGTTACGTTCTT
G-3′
Terminator loop
2: 35 +Trigger
i-15_ii-15a_t 5′-ACTTTCTCGAATAGCGGTTGATGGATGATA-3′ 5′ extension: 15 /
Handle loop: 15a
+Trigger
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Insert studies in E. coli
Part name Candidate cgRNA/trigger sequence Legend
i-25_ii-25a_t 5′-GGGATCTGAAACTTTCTCGAATAGCGGTTGATGGA
TGATAAGTCTATAGT-3′
5′ extension: 25 /
Handle loop: 25a
+Trigger
i-35_ii-35_t 5′-CACGGAACACGGGATCTGAAACTTTCTCGAATAGC
GGTTGATGGATGATAAGTCTATAGTAATGAGTAGC-3′
5′ extension: 35 /
Handle loop: 35
+Trigger
i-15_iii-15a_t 5′-ATTGTGGTAAGGTTTGGTTGATGGATGATA-3′ 5′ extension: 15 /
Term loop 1: 15a
+Trigger
i-25_iii-25a_t 5′-GAATGGTGAAATTGTGGTAAGGTTTGGTTGATGGA
TGATAAGTCTATAGT-3′
5′ extension: 25 /
Term loop 1: 25a
+Trigger
i-35_iii-35_t 5′-GTGCTTATGTGAATGGTGAAATTGTGGTAAGGTTT
GGTTGATGGATGATAAGTCTATAGTAATGAGTAGC-3′
5′ extension: 35 /
Term loop 1: 35
+Trigger
i-15_iv-15_t 5′-ATTGTTACGTTCTTGGGTTGATGGATGATA-3′ 5′ extension: 15 /
Term loop 2: 15
+Trigger
i-25_iv-25_t 5′-TTCTGTTCTCATTGTTACGTTCTTGGGTTGATGGA
TGATAAGTCTATAGT-3′
5′ extension: 25 /
Term loop 2: 25
+Trigger
i-35_iv-35_t 5′-TATTTCTATCTTCTGTTCTCATTGTTACGTTCTTG
GGTTGATGGATGATAAGTCTATAGTAATGAGTAGC-3′
5′ extension: 35 /
Term loop 2: 35
+Trigger
ii-15b_iii-15a_t 5′-ATTGTGGTAAGGTTTCACGGAACACGGGAT-3′ Handle loop: 15b
/ Term loop 1:
15a +Trigger
ii-25b_iii-25a_t 5′-GAATGGTGAAATTGTGGTAAGGTTTCACGGAACAC
GGGATCTGAAACTTT-3′
Handle loop: 25b
/ Term loop 1:
25a +Trigger
ii-35_iii-35_t 5′-GTGCTTATGTGAATGGTGAAATTGTGGTAAGGTTT
CACGGAACACGGGATCTGAAACTTTCTCGAATAGC-3′
Handle loop: 35 /
Term loop 1: 35
+Trigger
ii-15b_iv-15_t 5′-ATTGTTACGTTCTTGCACGGAACACGGGAT-3′ Handle loop: 15b
/ Term loop 2: 15
+Trigger
ii-25b_iv-25_t 5′-TTCTGTTCTCATTGTTACGTTCTTGCACGGAACAC
GGGATCTGAAACTTT-3′
Handle loop: 25b
/ Term loop 2: 25
+Trigger
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Insert studies in E. coli
Part name Candidate cgRNA/trigger sequence Legend
ii-35_iv-35_t 5′-TATTTCTATCTTCTGTTCTCATTGTTACGTTCTTG
CACGGAACACGGGATCTGAAACTTTCTCGAATAGC-3′
Handle loop: 35 /
Term loop 2: 35
+Trigger
iii-15b_iv-15_t 5′-ATTGTTACGTTCTTGGTGCTTATGTGAATG-3′ Term loop 1: 15b
/ Term loop 2: 15
+Trigger
iii-25b_iv-25_t 5′-TTCTGTTCTCATTGTTACGTTCTTGGTGCTTATGT
GAATGGTGAAATTGT-3′
Term loop 1: 25b
/ Term loop 2: 25
+Trigger
iii-35_iv-35_t 5′-TATTTCTATCTTCTGTTCTCATTGTTACGTTCTTG
GTGCTTATGTGAATGGTGAAATTGTGGTAAGGTTT-3′
Term loop 1: 35
/ Term loop 2: 35
+Trigger
Table A.4: Candidate cgRNA/trigger sequences for insert studies in E. coli (Chapter
3). Nucleotides shaded orange are constrained by the target gene. Nucleotides
shaded gray are constrained by dCas9. Nucleotides shaded blue are designed as
described in Chapter 3.
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Splinted switch mechanism in E. coli
Name Sequence Legend
SplS_cgA 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTACACCTTACGCC
GGTTCAATTCCAAGTCCCTTCCAGTAGCAAGTTAAAATAAGGCTAG
TCCGTTATCAACTTAACACCCTTTACAAACCTTCCTCTTCCTTTAC
CCTAAGTGGCACCGAGTCGGTGCTTTTTTT-3′
cgRNA
cgRNA A
SplS_cgB 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGTAATCGAATC
ATAGTAAATTTCCCATCGTCATAATAGCAAGTTAAAATAAGGCTAG
TCCGTTATCAACTTCATACGGGTCTGAAGTAGTTCATTCTTATACA
GTCAAGTGGCACCGAGTCGGTGCTTTTTTT-3′
cgRNA B
SplS_cgC 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGTCGTTACCTT
ATCAATATCAACCTCCGCATACACTAGCAAGTTAAAATAAGGCTAG
TCCGTTATCAACTTGCACATAGGACCCAACATGCCAACAGAGAAGA
GTTAAGTGGCACCGAGTCGGTGCTTTTTTT-3′
cgRNA C
SplS_cgD 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAAACATACAAAC
CACTACCGACAACTTAAACACTTTTAGCAAGTTAAAATAAGGCTAG
TCCGTTATCAACTTTCACTACATCATATCATACGCGGAATTAAACA
ATCAAGTGGCACCGAGTCGGTGCTTTTTTT-3′
cgRNA D
SplS_tA 5′-AGGGTAAAGGAAGAGGAAGGTTTGTAAAGGGTGTTCTGGAAGG
GACTTGGAATTGAACCGGCGTAAGGTG-3′
Trigger
Trigger XA
SplS_tB 5′-GACTGTATAAGAATGAACTACTTCAGACCCGTATGTTATGACG
ATGGGAAATTTACTATGATTCGATTAC-3′
Trigger XB
SplS_tC 5′-AACTCTTCTCTGTTGGCATGTTGGGTCCTATGTGCGTGTATGC
GGAGGTTGATATTGATAAGGTAACGAC-3′
Trigger XC
SplS_tD 5′-GATTGTTTAATTCCGCGTATGATATGATGTAGTGAAAAGTGTT
TAAGTTGTCGGTAGTGGTTTGTATGTT-3′
Trigger XD
Table A.5: Splinted switch sequences for studies in E. coli (Chapter 4). Nucleotides
shaded orange are constrained by the target gene. Nucleotides shaded gray are con-
strained by dCas9. Nucleotides shaded blue are designed as described in Chapter 4.
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Toehold switch mechanism in E. coli
Name Sequence Legend
ToeS_cgA 5′-ATGTTCGTTGTATTAAGACCGCTAAACTGAAAGTTACACGCC
CAACTTTCAGTTTAGCGGTCTGTTTTAGAGCTAGAAATAGCAAGTT
AAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTC
GGTGCTTTTTTT-3′
cgRNA
cgRNA A
ToeS_cgB 5′-GTATATGAAATTGAAAGACCGCTAAACTGAAAGTTACACGCC
CAACTTTCAGTTTAGCGGTCTGTTTTAGAGCTAGAAATAGCAAGTT
AAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTC
GGTGCTTTTTTT-3′
cgRNA B
ToeS_cgC 5′-AAGGTGATAGTAAAGAGACCGCTAAACTGAAAGTTACACGCC
CAACTTTCAGTTTAGCGGTCTGTTTTAGAGCTAGAAATAGCAAGTT
AAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTC
GGTGCTTTTTTT-3′
cgRNA C
ToeS_cgD 5′-TATACTTATACTTGGAGACCGCTAAACTGAAAGTTACACGCC
CAACTTTCAGTTTAGCGGTCTGTTTTAGAGCTAGAAATAGCAAGTT
AAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTC
GGTGCTTTTTTT-3′
cgRNA D
ToeS_tA 5′-AACTTTCAGTTTAGCGGTCTTAATACAACGAACAT-3′ Trigger
Trigger XA
ToeS_tB 5′-AACTTTCAGTTTAGCGGTCTTTCAATTTCATATAC-3′ Trigger XB
ToeS_tC 5′-AACTTTCAGTTTAGCGGTCTCTTTACTATCACCTT-3′ Trigger XC
ToeS_tD 5′-AACTTTCAGTTTAGCGGTCTCCAAGTATAAGTATA-3′ Trigger XD
Table A.6: Toehold switch sequences for studies in E. coli (Chapter 5). Nucleotides
shaded orange are constrained by the target gene. Nucleotides shaded gray are con-
strained by dCas9. Nucleotides shaded blue are designed as described in Chapter 5.
Control gRNA sequences
Name Sequence
CT_g 5′-CACATCCCATCCACCGCCACGTTTTAGAGCTAGAAATAGCAAGTTAAAAT
AAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTT T-3′
mRFP_g 5′-AACTTTCAGTTTAGCGGTCTGTTTTAGAGCTAGAAATAGCAAGTTAAAAT
AAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTT T-3′
sfGFP_g 5′-CATCTAATTCAACAAGAATTGTTTTAGAGCTAGAAATAGCAAGTTAAAAT
AAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGAGTCGGTGCTTTTTT T-3′
NT_g 5′-GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAAC
TTGAAAAAGTGGCACCGAGTCGGTGCTTTTTTT-3′
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Table A.7: Control gRNA sequences. For the standard gRNAs, nucleotides shaded
orange are constrained by the target gene (mRFP or sfGFP for bacterial studies) or
target dsDNA sequence (CT gRNA binding site or sfGFP binding site for in vitro
studies). Nucleotides shaded gray are constrained by Cas protein. The no-target
gRNA contains no target-binding region. For bacterial studies, the autofluorescence
control strain was transformed with the no-target gRNA control plasmid (sequence
NT_g).
Transcriptional promoter and terminator sequences
Name Type Sequence
T7_E T7 promoter 5′-CCTCTAATACGACTCACTATA-3′
BBa_J23100 Constitutive promoter 5′-TTGACGGCTAGCTCAGTCCTAGGTACAGTGCTAG
C-3′
BBa_J23108 Constitutive promoter 5′-CTGACAGCTAGCTCAGTCCTAGGTATAATGCTAG
C-3′
BBa_J23114 Constitutive promoter 5′-TTTATGGCTAGCTCAGTCCTAGGTACAATGCTAG
C-3′
BBa_R0011 lacI-regulated promoter 5′-AATTGTGAGCGGATAACAATTGACATTGTGAGCGG
ATAACAAGATACTGAGCACA-3′
BBa_B0015 Terminator 5′-CCAGGCATCAAATAAAACGAAAGGCTCAGTCGAAA
GACTGGGCCTTTCGTTTTATCTGTTGTTTGTCGGTGA
ACGCTCTCTACTAGAGTCACACTGGCTCACCTTCGGG
TGGGCCTTTCTGCGTTTATA-3′
BBa_B0050 Terminator 5′-AAAAAAAGGATCTCAAGAAGATCCTTTGATTT
T-3′
BBa_B1006 Terminator 5′-AAAAAAAAACCCCGCCCCTGACAGGGCGGGGTTTT
TTTT-3′
BBa_B1010 Terminator 5′-CGCCGCAAACCCCGCCCCTGACAGGGCGGGGTTTC
GCCGC-3′
Table A.8: Transcriptional promoter and terminator sequences.
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A.6 Sequences for dsDNA target
dsDNA target sequence for in vitro cleavage assay
Nucleotides highlighted in orange indicate the control gRNA (CT_g) target sequence (cleavage site
for assay of Figure 2.1). Nucleotides highlighted in green indicate the sfGFP target sequence (cleav-
age site for assay of Figures 2.4, 2.5, and 2.6).
1 TATGTAAAAC CTGTGACATT TCCCATCTTT GAAACTATTT AGTACTTTGT ATTTCTCACA
61 AGCACTTAGA GGCTGCCTTC TATTATAGTT ATTTACAGAG ATGCCTTTCC TCCTTTCATA
121 TTAAGCTGAA TCCCTATTCC TCTCTTACTA ATCTTTCTAT AGCCCGTAAT ATCCACCTAA
181 CTAGTATAGT CACTTACATA GAGGGCATGT TTAATAGAAA CTTGATGAAT TGAATGGAGC
241 AAAAAAAATC AAATAGGCAA AAACCATATC TACGTTAGAG GCTCATGAAG TATCACAAAA
301 GCAAAGGAAA CACATACAAA AAATTGTCTC ATACACACAC ACACACACAA TGGGCAATAA
361 ACACAAAGTT CAAAAACGTT GTCCTCAGCA CGGCGTCGCG TGCGAGGACC TCTTTTGATT
421 AGGGCGTGCA GCCGTGGCCT CAGCTGTCTT TTTTCTTGAT CCTCCTACAT TAGATGACTC
481 TGGGATTTTC TTGTTGCCCC TTTGCAGCCC ACCATGAGCT GATTTTGTGA AGACTTTGAC
541 TTTACTTAAA TTGACTGCTT CAGATTCTGT ATTAATAAGG TGATCTGATC TCTTCTGACA
601 CGCTCCTTCC TGCAGTGAAT TTGACTTTCT ACATCTCTTT TTTTGACGCT GTGACCTCTC
661 ACTAGAAAGT TCCACAGAAA GCTGACTCTC ATGTAAAGTA CTTGCATCAA ATTCTAAATC
721 ACTTAAAGAT TTTTCTGCTT TCCTCTTGCA CAATTCTTGT TGAATTAGAT GAGGACTTGG
781 AACTGGATTT AAGTTTATCC CTTCTAATGC ACTTTCCCCT AGCAATTTCT CTTCCTTTCT
841 TTTGGGAGGT AGTCCAAAAT ACACACCTAT ATCCATTTGC TTCATTACCT TGGTAGAAGG
901 ATGTCTTGCA TTATACTTAA GACCAGAAGG CAATATTTTC AAATACTTCG GAGCAGGTGT
961 ACTAGACAAG TTTTCTGTAT TTAAAATTGT AGCTTTACCA ACTGGCACAC CCTCTAATGC
1021 CTTTCTGCAG AAACATGCTG AGTTAGTATT ATTCTTAGCA TTCAAGTTCT CACTTGATAA
1081 TCTTCTAATT GTATTTTGGG TTGGTTGGGA AGAAAGATAC CCTTCTACCT GACTTTCAAA
1141 AGGTTTCAAC
Ec001 genomically incorporated mRFP template sequence
Nucleotides highlighted in orange indicate the gRNA/cgRNA target sequence.
1 ATGGCGAGTA GCGAAGACGT TATCAAAGAG TTCATGCGTT TCAAAGTTCG TATGGAAGGT
61 TCCGTTAACG GTCACGAGTT CGAAATCGAA GGTGAAGGTG AAGGTCGTCC GTACGAAGGT
121 ACCCAGACCG CTAAACTGAA AGTTACCAAA GGTGGTCCGC TGCCGTTCGC TTGGGACATC
181 CTGTCCCCGC AGTTCCAGTA CGGTTCCAAA GCTTACGTTA AACACCCGGC TGACATCCCG
241 GACTACCTGA AACTGTCCTT CCCGGAAGGT TTCAAATGGG AACGTGTTAT GAACTTCGAA
301 GACGGTGGTG TTGTTACCGT TACCCAGGAC TCCTCCCTGC AAGACGGTGA GTTCATCTAC
361 AAAGTTAAAC TGCGTGGTAC CAACTTCCCG TCCGACGGTC CGGTTATGCA GAAAAAAACC
421 ATGGGTTGGG AAGCTTCCAC CGAACGTATG TACCCGGAAG ACGGTGCTCT GAAAGGTGAA
481 ATCAAAATGC GTCTGAAACT GAAAGACGGT GGTCACTACG ACGCTGAAGT TAAAACCACC
541 TACATGGCTA AAAAACCGGT TCAGCTGCCG GGTGCTTACA AAACCGACAT CAAACTGGAC
601 ATCACCTCCC ACAACGAAGA CTACACCATC GTTGAACAGT ACGAACGTGC TGAAGGTCGT
661 CACTCCACCG GTGCTTAA
92
Ec001 genomically incorporated sfGFP template sequence
Nucleotides highlighted in orange indicate the gRNA/cgRNA target sequence.
1 ATGAGCAAAG GAGAAGAACT TTTCACTGGA GTTGTCCCAA TTCTTGTTGA ATTAGATGGT
61 GATGTTAATG GGCACAAATT TTCTGTCCGT GGAGAGGGTG AAGGTGATGC TACAAACGGA
121 AAACTCACCC TTAAATTTAT TTGCACTACT GGAAAACTAC CTGTTCCGTG GCCAACACTT
181 GTCACTACTC TGACCTATGG TGTTCAATGC TTTTCCCGTT ATCCGGATCA CATGAAACGG
241 CATGACTTTT TCAAGAGTGC CATGCCCGAA GGTTATGTAC AGGAACGCAC TATATCTTTC
301 AAAGATGACG GGACCTACAA GACGCGTGCT GAAGTCAAGT TTGAAGGTGA TACCCTTGTT
361 AATCGTATCG AGTTAAAGGG TATTGATTTT AAAGAAGATG GAAACATTCT TGGACACAAA
421 CTCGAGTACA ACTTTAACTC ACACAATGTA TACATCACGG CAGACAAACA AAAGAATGGA
481 ATCAAAGCTA ACTTCAAAAT TCGCCACAAC GTTGAAGATG GTTCCGTTCA ACTAGCAGAC
541 CATTATCAAC AAAATACTCC AATTGGCGAT GGCCCTGTCC TTTTACCAGA CAACCATTAC
601 CTGTCGACAC AATCTGTCCT TTCGAAAGAT CCCAACGAAA AGCGTGACCA CATGGTCCTT
661 CTTGAGTTTG TAACTGCTGC TGGGATTACA CATGGCATGG ATGAGCTCTA CAAA
93
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SUPPLEMENTARY FIGURES AND DATA FOR CHAPTER 2
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Figure B.1: Quantifying in vitro cgRNA insert study (cf. Figure 2.4). Non-
denaturing PAGE (4-20% 1xTBE polyacrilimide gel) of reaction products for single
5′ extension inserts, single handle loop inserts, and for each of four 5′ exten-
sion/handle insert splinted switch cgRNAs (A, B, C, and D). gRNA or candidate
cgRNA was pre-incubated with recombinant Cas9 (10 min) prior to addition of
dsDNA target (final reaction concentrations: 30 nM (c)gRNA, 3 nM dsDNA cleav-
age target). All gRNA and cgRNA containing lanes include Cas9 and dsDNA
target. Magenta boxes were used for mean pixel intensity quantification of signal
+ background for Figure 2.4b, orange boxes were used for mean pixel intensity
quantification of subtracted background.
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Figure B.2: Additional reaction conditions and quantification of in vitro cgRNAs
(cont’d). (a) cgRNA A. (b) cgRNA B. (c) cgRNA C. (d) cgRNA D. Non-denaturing
PAGE (4-20%1xTBE polyacrilimide gel) of reaction products for single 5′ extension
inserts, single handle loop inserts, and for each of four 5′ extension/handle insert
splinted switch cgRNAs (A, B, C, andD)with cognate trigger at a 2:1molar ratio and
each of four synthetic RNA triggers (XA, XB, XC , XD) at a 10:1 molar ratio. cgRNA
was snap-cooled with RNA trigger in buffer and pre-incubated with recombinant
Cas9 (10 min) prior to addition of dsDNA target (final reaction concentrations: 30
nM cgRNA, 60 nM or 300 nM RNA trigger, 3 nM dsDNA cleavage target). All
gRNA and cgRNA containing lanes include Cas9 and dsDNA target. Magenta boxes
were used for mean pixel intensity quantification of signal + background for Figure
2.5b, orange boxes were used for mean pixel intensity quantification of subtracted
background.
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Table C.1: Quantifying ON state, OFF state, fold change, and dynamic range for
gRNA insert studies, 0.2 nM aTc (cont’d). ON = (cgRNA, no trigger) − AF; OFF
= (cgRNA + cognate trigger) − AF; fold change = OFF/ON; dynamic range =
OFF−ON; fractional dynamic range = [OFF−ON]/[ideal OFF − ideal ON]. Ideal
values correspond to a standard gRNA for ideal ON and a no-target gRNA for ideal
OFF. Autofluorescence values (AF) were 120 ± 8 (panel a), 102 ± 2 (panel b), and
113 ± 9 (panel c). Mean ± estimated standard error (with uncertainty propagation)
based on the mean single-cell fluorescence over 20,000 cells for each of N = 3
replicate wells.
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Table C.2: Quantifying ON state, OFF state, fold change, and dynamic range for
gRNA insert studies, 2 nM aTc (cont’d). ON = (cgRNA, no trigger) − AF; OFF
= (cgRNA + cognate trigger) − AF; fold change = OFF/ON; dynamic range =
OFF−ON; fractional dynamic range = [OFF−ON]/[ideal OFF − ideal ON]. Ideal
values correspond to a standard gRNA for ideal ON and a no-target gRNA for ideal
OFF. Autofluorescence values (AF) were 106 ± 10 (panel a), 85 ± 8 (panel b), and
87 ± 5 (panel c). Mean ± estimated standard error (with uncertainty propagation)
based on the mean single-cell fluorescence over 20,000 cells for each of N = 3
replicate wells.
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Table C.3: Quantifying ON state, OFF state, fold change, and dynamic range for
gRNA insert studies, 20 nM aTc (cont’d). ON = (cgRNA, no trigger) − AF; OFF
= (cgRNA + cognate trigger) − AF; fold change = OFF/ON; dynamic range =
OFF−ON; fractional dynamic range = [OFF−ON]/[ideal OFF − ideal ON]. Ideal
values correspond to a standard gRNA for ideal ON and a no-target gRNA for ideal
OFF. Autofluorescence values (AF) were 80 ± 10 (panel a), 68 ± 2 (panel b), and
80 ± 20 (panel c). Mean ± estimated standard error (with uncertainty propagation)
based on the mean single-cell fluorescence over 20,000 cells for each of N = 3
replicate wells.
cgRNA ∆GcgRNA ∆Gtrigger ∆GcgRNA:trigger ∆∆Ghybridization
5′ extension: 15 −28.87 −25.55 −78.86 −24.44
5′ extension: 25 −29.85 −30.95 −94.26 −33.46
5′ extension: 35 −30.1 −31.75 −112.23 −50.38
Handle loop: 15a −31.06 −25.63 −74.67 −17.98
Handle loop: 15b −26.91 −27.08 −79.05 −25.06
Handle loop: 25a −31.11 −28.38 −94.37 −34.88
Handle loop: 25b −27.38 −28.86 −94.52 −38.28
Handle loop: 35 −32.81 −30.43 −113.93 −50.69
Terminator loop 1: 15a −28.38 −25.52 −75.42 −21.52
Terminator loop 1: 15b −27.48 −27.23 −77.23 −22.52
Terminator loop 1: 25a −28.45 −26.93 −92.5 −37.12
Terminator loop 1: 25b −27.66 −27.19 −92.78 −37.93
Terminator loop 1: 35 −28.62 −28.48 −110.13 −53.03
Terminator loop 2: 15 −27.72 −25.44 −66.31 −13.15
Terminator loop 2: 25 −27.98 −26.22 −84.32 −30.12
Terminator loop 2: 35 −27.89 −26.49 −98.1 −43.72
5′ extension: 15 / Handle loop: 15a −31.14 −29.19 −92.41 −32.08
5′ extension: 25 / Handle loop: 25a −32.18 −34.49 −127.51 −60.84
5′ extension: 35 / Handle loop: 35 −34.25 −38.08 −165.03 −92.7
5′ extension: 15 / Term loop 1: 15a −28.46 −26.73 −93.08 −37.89
5′ extension: 25 / Term loop 1: 25 −29.32 −32.78 −125.55 −63.45
5′ extension: 35 / Term loop 1: 35 −29.8 −35.62 −161.14 −95.72
5′ extension: 15 / Term loop 2: 15 −27.81 −28.84 −85.6 −28.95
5′ extension: 25 / Term loop 2: 25 −29.04 −32.98 −119 −56.98
5′ extension: 35 / Term loop 2: 35 −29.21 −37.63 −150.75 −83.91
Handle loop: 15b / Term loop 1: 15a −26.46 −29.31 −92.84 −37.07
Handle loop: 25b / Termloop 1: 25a −26.93 −35.73 −125.38 −62.72
Handle loop: 35 / Term loop 1: 35 −32.49 −40.09 −162.42 −89.84
Handle loop: 15b / Term loop 2: 15 −25.85 −31.51 −85.91 −28.55
Handle loop: 25b / Term loop 2: 25 −26.59 −35.49 −119.39 −57.31
Handle loop: 35 / Term loop 2: 35 −31.92 −39.23 −152.59 −81.44
Term loop 1: 15b / Term loop 2: 15 −26.44 −28.98 −82.29 −26.87
Term loop 1: 25b / Term loop 2: 25 −26.91 −33.38 −115.86 −55.57
Term loop 1: 35 / Term loop 2: 35 −27.75 −36.22 −146.99 −83.02
Table C.4: Free energy of cgRNA/trigger complexes and trigger hybridization for
candidate cgRNAs with single and double inserts predicted via NUPACK analysis.
∆∆G values calculated using NUPACK analysis with RNA in 1 M Na+ at 37 ◦C,38
∆∆Ghybridization = ∆GcgRNA:trigger − [∆GcgRNA + ∆Gtrigger].
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Figure C.1: Fractional dynamic range vs predicted ∆∆G of trigger binding for all
single and double insert candidate cgRNAs. (a) 0.2 nM aTc induction of dCas9.
(b) 2 nM aTc induction of dCas9. (c) 20 nM aTc induction of dCas9. Fractional
dynamic range is higher for cgRNA:trigger pairs with high |∆∆G|, but is reduced
with increased dCas9 induction. ∆∆G values calculated using NUPACK analysis
(RNA in 1MNa+ at 37 ◦C,38 ∆∆G=∆GcgRNA:trigger − [∆GcgRNA +∆Gtrigger]). Slope
of fitted line and mean squared error (MSE) indicate a weaker effect of trigger as
compared to analysis with handle loop insert containing candidate cgRNAs only
(Figure 3.4). Fractional dynamic range: mean ± estimated standard error based on
N = 3 replicate wells with uncertainty propagation. Fitted lines calculated using
least squares regression weighted by inverse estimate of variance of the mean.118
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Figure D.1: Analysis of design quality by equilibrium pair probability for splinted
switch cgRNA:trigger XA duplex.34,35 Nucleotides shaded and scaled to indicate the
probability of adopting the depicted base-pairing state at equilibrium. Pairing states
in the target structure indicated with black circles. For this design, all on-target
complexes are predicted to form with quantitative yield at the 10 nM target con-
centration, but some nucleotides have unwanted base-pairing interactions (circled
pairs not shaded dark red, uncircled pairs with significant pair probability), no-
tably the low-probability of the target constrained (orange) and dCas9 constrained
(grey) sequence adopting their intended structure. For the cgRNA:trigger complex,
constrained sequence was assigned the lowest weight (w=0) for design; here, the de-
signed sequence appears to adopt the intended target structure with high probability,
and as such, this design was selected for experimental characterization.
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Figure D.2: Flow cytometry replicates for splinted switch ON state, OFF state, and
conditional response in E. coli. Single-cell fluorescence intensities. Expression
of RNA trigger X toggles the cgRNA from ON→OFF, leading to an increase
in fluorescence. Induced expression (aTc) of silencing dCas9 and constitutive
expression of sfGFP target gene Y and either: standard gRNA (ideal ON state),
cgRNA (ON state), cgRNA + RNA trigger X (OFF state), or no-target gRNA that
lacks target-binding region (ideal OFF state). Autofluorescence: cells with no
sfGFP. Traces of the same color correspond to N = 3 replicate wells assayed on the
same day (20,000 cells per well).
cgRNA ON OFF Fold Change Dynamic Range Fractional
Dynamic Range
Ideal 100 ± 40 35 450 ± 80 300 ± 100 35 350 ± 70 1
cgRNA A 150 ± 40 2270 ± 50 15 ± 4 2120 ± 30 0.0599 ± 0.0008
cgRNA B 140 ± 40 2450 ± 50 18 ± 5 2310 ± 30 0.0654 ± 0.0009
cgRNA C 160 ± 40 1320 ± 70 8 ± 2 1160 ± 60 0.033 ± 0.002
Table D.1: Quantifying ON state, OFF state, fold change, and dynamic range for
splinted switch cgRNA in E. coli. Autofluorescence (AF) value was 3210 ± 40.
Ideal values correspond to a standard gRNA for ideal ON and a no-target gRNA
for ideal OFF. Using silencing dCas9 in E. coli: fold change = OFF/ON, dynamic
range = OFF−ON, fractional dynamic range = [OFF−ON]/[ideal OFF − ideal ON].
Mean ± estimated standard error (with uncertainty propagation) based on the mean
single-cell fluorescence over 20,000 cells for each of N = 3 replicate wells.
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Figure D.3: Flow cytometry replicates for splinted switch orthogonal response
in E. coli. (a) cgRNA A. (b) cgRNA B. (c) cgRNA C. Single-cell fluorescence
intensities. Induced expression (aTc) of silencing dCas9 and constitutive expression
of sfGFP target gene Y and either: standard gRNA, cgRNA without trigger, cgRNA
+ cognate trigger, or cgRNA + a noncognate trigger. Autofluorescence: cells with
no sfGFP. Expression of the cognate RNA trigger (XA for cgRNA A, XB for cgRNA
B, XC for cgRNA C) toggles the cgRNA from ON→OFF, leading to an increase in
fluorescence. Traces of the same color correspond to N = 3 replicate wells assayed
on the same day (20,000 cells per well).
cgRNA Trigger Signal Crosstalk
A no trigger 150 ± 40
A A 2270 ± 50 1.00 ± 0.02
A B 110 ± 40 −0.019 ± 0.003
A C 110 ± 40 −0.021 ± 0.005
B no trigger 140 ± 40
B A 190 ± 40 0.021 ± 0.006
B B 2450 ± 50 1.00 ± 0.02
B C 420 ± 40 0.122 ± 0.007
C no trigger 160 ± 40
C A 380 ± 40 0.19 ± 0.02
C B 150 ± 40 −0.007 ± 0.011
C C 1320 ± 70 1.00 ± 0.07
Table D.2: Quantifying crosstalk for cognate and non-cognate splinted switch
cgRNA/trigger pairs in E. coli. Autofluorescence (AF) value was 210 ± 40. Mean ±
estimated standard error (with uncertainty propagation) based on the mean single-
cell fluorescence over 20,000 cells for each of N = 3 replicate wells.
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Figure E.1: Flow cytometry replicates for toehold switch ON state, OFF state, and
conditional response in E. coli. Single-cell fluorescence intensities. Expression of
RNA trigger X toggles the cgRNA from OFF→ON, leading to a decrease in fluo-
rescence. Induced expression (aTc) of silencing dCas9 and constitutive expression
of mRFP target gene Y and either: no-target gRNA that lacks target-binding region
(ideal OFF state), cgRNA (OFF state), cgRNA + RNA trigger X (ON state), or
standard gRNA (ideal ON state). Autofluorescence: cells with no mRFP. Traces of
the same color correspond to N = 3 replicate wells assayed on the same day (20,000
cells per well).
cgRNA ON OFF Fold Change Dynamic Range Fractional
Dynamic Range
Ideal 340 ± 30 102 000 ± 4000 300 ± 30 102 000 ± 4000 1
cgRNA A 4400 ± 200 18 400 ± 400 4.2 ± 0.2 14 000 ± 500 0.138 ± 0.007
cgRNA B 10 200 ± 400 16 000 ± 300 1.57 ± 0.07 5800 ± 500 0.057 ± 0.005
cgRNA C 4890 ± 110 15 300 ± 500 3.13 ± 0.12 10 400 ± 500 0.102 ± 0.006
Table E.1: Quantifying ON state, OFF state, fold change, and dynamic range for
toehold switch cgRNA in E. coli. Autofluorescence (AF) value was 33 ± 2. Ideal
values correspond to a standard gRNA for ideal ON and a no-target gRNA for
ideal OFF. Using silencing dCas9 in E. coli: fold change = OFF/ON, dynamic
range = OFF−ON, fractional dynamic range = [OFF−ON]/[ideal OFF − ideal ON].
Mean ± estimated standard error (with uncertainty propagation) based on the mean
single-cell fluorescence over 20,000 cells for each of N = 3 replicate wells.
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Figure E.2: Flow cytometry replicates for toehold switch orthogonal response in
E. coli. Flow cytometry fluorescence assay shows selective activation of Toehold
Switch cgRNA with expression of cognate RNA trigger. (a) cgRNA A. (b) cgRNA
B. (c) cgRNA C. Single-cell fluorescence intensities. Induced expression (aTc)
of silencing dCas9 and constitutive expression of mRFP target gene Y and either:
standard gRNA, cgRNA without trigger, cgRNA + cognate trigger, or cgRNA +
a noncognate trigger. Autofluorescence: cells with no mRFP. Expression of the
cognate RNA trigger (XA for cgRNA A, XB for cgRNA B, XC for cgRNA C)
toggles the cgRNA from OFF→ON, leading to decrease in fluorescence. Traces of
the same color correspond to N = 3 replicate wells assayed on the same day (20,000
cells per well).
cgRNA Trigger Signal Crosstalk
A no trigger 18 400 ± 400
A A 4400 ± 200 1.00 ± 0.05
A B 14 100 ± 300 0.31 ± 0.04
A C 12 800 ± 400 0.40 ± 0.05
B no trigger 16 000 ± 300
B A 17 500 ± 900 −0.3 ± 0.2
B B 10 200 ± 400 1.00 ± 0.12
B C 18 500 ± 600 −0.43 ± 0.12
C no trigger 15 300 ± 500
C A 14 000 ± 500 0.12 ± 0.07
C B 13 000 ± 60 0.22 ± 0.05
C C 4890 ± 110 1.00 ± 0.06
Table E.2: Quantifying crosstalk for cognate and non-cognate toehold switch
cgRNA/trigger pairs inE. coli. Autofluorescence (AF) value was 33± 2. Mean± es-
timated standard error (with uncertainty propagation) based on the mean single-cell
fluorescence over 20,000 cells for each of N = 3 replicate wells.
